clopidogrel has been researched along with Coronary Disease in 444 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (3.38) | 18.2507 |
| 2000's | 302 (68.02) | 29.6817 |
| 2010's | 118 (26.58) | 24.3611 |
| 2020's | 9 (2.03) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Cui, YK; Dong, JZ; Du, X; Feng, L; He, L; Hu, R; Jia, CQ; Li, X; Long, DY; Lv, WH; Ma, CS; Ning, M; Sang, CH; Tang, RB | 1 |
| Chang, R; Liu, Y; Wu, J; Ye, Y; Zhang, X; Zhou, W | 1 |
| Chen, XP; Hu, XL; Li, DJ; Li, H; Li, ZY; Ma, QL; Zhang, YJ | 1 |
| Munthe, DHB; Sargo, SS; Yogiarto, M | 1 |
| Cannata, F; Cao, D; Chiarito, M; Condorelli, G; De Caterina, R; Ferrante, G; Godino, C; Panico, C; Regazzoli, D; Reimers, B; Sanz-Sánchez, J; Stefanini, GG; Sturla, M | 1 |
| Bellemain-Appaix, A; Beygui, F; Boccara, F; Boueri, Z; Brunel, P; Caussin, C; Cayla, G; Christiaens, L; Collet, JP; Dillinger, JG; Ducrocq, G; Dumaine, R; El Kasty, M; Georges, JL; Guedeney, P; Hauguel-Moreau, M; Jourda, F; Labeque, JN; Laredo, M; Lattuca, B; Le Breton, H; Lhermusier, T; Montalescot, G; Motovska, Z; Pouillot, C; Range, G; Saint-Etienne, C; Silvain, J; Vicaut, E | 1 |
| Chen, Y; Di, C; Wang, J; Xie, D; Xie, X; Yang, W; You, T; Zhang, A; Zhang, S; Zhang, X | 1 |
| Abdul Kader, MAS; Akkaif, MA; Daud, NAA; Ibrahim, B; Ng, ML; Noor, DAM; Sha'aban, A | 1 |
| Lagergren, J; Maret-Ouda, J; Rosengren, A; Santoni, G; Xie, S | 1 |
| Fang, W; Gan, Q; Han, W; Hou, X; Liu, Y | 2 |
| Huang, RC; Yuan, C; Zhong, L | 1 |
| Fu, DL; Gao, YX; Li, XL; Liu, XF; Lu, HK; Peng, WH; Wang, Q; Wang, Y; Yang, P; Zhang, H; Zhao, TT; Zheng, JG | 1 |
| Adriaenssens, T; Bernlochner, I; Byrne, RA; Colleran, R; Emmer, R; Fischer, M; Giacoppo, D; Han, Y; Harada, Y; Ibrahim, T; Jacobshagen, C; Kastrati, A; Kufner, S; Lahmann, AL; Laugwitz, KL; Lohaus, R; Maeng, M; Mayer, K; Mehilli, J; Michel, J; Morath, T; Neumann, FJ; Schulz-Schüpke, S; Schunkert, H; Seyfarth, M; Ten Berg, JM; Tölg, R; Wöhrle, J; Wolk, A; Zrenner, B | 1 |
| Chen, S; Geng, Y; Gu, J; Hao, Q; Qi, P; Wang, H; Wang, L; Zhang, Y | 1 |
| Li, KC; Yu, SH; Zhuge, BZ | 1 |
| Fu, WX; He, RX; Jing, QM; Liu, HW; Liu, YJ; Wang, XZ; Yuan, WJ; Zhang, L; Zhou, TN | 1 |
| Landmesser, U; Stähli, BE | 1 |
| Almassi, GH; Bakaeen, FG; Bishawi, M; Carr, BM; Collins, J; Ebrahimi, R; Grover, FL; Gupta, S; Hattler, B; Quin, JA; Shroyer, ALW; Wagner, TH | 1 |
| Chen, W; Hu, W; Kuang, X; Liu, Z; Tong, J | 1 |
| Cervantes, A; Cicci, JD; Clarke, M; Hamrick, K; Howell, LA; Lee, CR; Lee, JA; Madan, S; Polasek, MJ; Sriramoju, VB; Stouffer, GA; Varunok, N; Weck, KE | 1 |
| Chang, H; Guo, MZ; Ji, S; Tang, DQ; Wang, TY; Yang, J | 1 |
| Gong, Y; Pan, Y; Song, Y; Wu, Y; Zhou, Y | 1 |
| Cai, X; Ding, H; Luo, C; Shen, C; Wu, B; Yang, H | 1 |
| Dimmitt, SB; Ferner, RE; Floyd, CN | 1 |
| Carrillo-Alemán, L; Esteve-Pastor, MA; Lozano, T; Macías-Villanego, MJ; Marín, F; Martínez, J; Orenes-Piñero, E; Pernías-Escrig, V; Quintana-Giner, M; Rivera-Caravaca, JM; Ruiz-Nodar, JM; Sandín-Rollán, M; Tello-Montoliú, A; Veliz-Martínez, A; Vicente-Ibarra, N | 1 |
| Ge, L; Ji, WJ; Jiang, TM; Li, YM; Liu, X; Lu, RY; Shi, R; Zeng, S; Zhang, WC; Zhang, YY; Zhao, JH; Zhou, X | 1 |
| Cattaneo, M | 3 |
| Bonzi, M; Fiorelli, EM | 1 |
| Lee, R; Lee, T | 1 |
| Brodie, BR; Cox, DA; Duffy, PL; Gurbel, PA; Henry, TD; Kirtane, AJ; Mazzaferri, E; Mehran, R; Metzger, DC; Neumann, FJ; Parise, H; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Xu, K | 1 |
| Curkovic, I; Egbring, M; Kullak-Ublick, GA | 1 |
| Gong, XX; Li, CJ; Wang, XZ; Yang, ZJ; Zhu, TT | 1 |
| Almassi, GH; Ardehali, A; Bakaeen, FG; Baltz, JH; Collins, JF; Ebrahimi, R; Grover, FL; Hattler, B; Shroyer, AL; Uberoi, A; Wagner, TH | 1 |
| Li, G; Li, ZQ; Yang, JD; Yang, QY | 1 |
| Coxson, PG; Goldman, L; Gu, D; He, J; Heidenreich, PA; Liu, J; Moran, AE; Wang, M; Zhao, D | 1 |
| Afanas'ev, SA; Muslimova, EF; Rebrova, TIu; Repin, AN; Sergienko, TN | 1 |
| Jiang, JJ; Tang, H; Xie, YM; Yang, H; Zhuang, Y | 1 |
| Chang, YP; Hu, J; Xie, YM; Zeng, XB; Zhang, H; Zhuang, Y | 1 |
| Garay-Sánchez, P; Limiñana, JM; Martínez-Quintana, E; Medina-Gil, JM; Rodríguez-González, F; Saavedra, P; Tugores, A | 1 |
| Ding, X; Gao, J; Hang, Y; Jiang, B; Miao, L; Wang, H; Xie, C; Zhang, H; Zhang, J | 1 |
| Guo, WY; He, Y; Li, Y; Liu, T; Si, R; Song, LQ; Wang, HC; Yin, T; Yu, J; Zhang, YM | 1 |
| Barbosa, SP; Bianco, HT; Camargo, LM; Fonseca, FA; França, CN; Izar, MC; Lins, LS; Pinheiro, LF | 1 |
| Chrzczanowicz, J; Drygas, W; Gawron-Skarbek, A; Jegier, A; Kostka, J; Kostka, T; Nowak, D | 1 |
| Fauchère, I; Schreiber, P; Wyss, C | 1 |
| Davlouros, P; Kounis, NG | 1 |
| Abdel Gader, AM; Al Shamiri, MQ; Bayoumy, NM | 1 |
| Ikeda, Y; Isshiki, T; Kimura, T; Kitagawa, K; Miyazaki, S; Nakamura, M; Nanto, S; Nishikawa, M; Ogawa, H; Saito, S; Takayama, M; Yokoi, H | 1 |
| Jaben, EA; Mulay, SB; Stubbs, JR | 1 |
| Jiang, HY; Jiang, JJ; Li, GH; Wang, YY; Xie, YM; Yang, W; Zhao, W; Zhuang, Y | 1 |
| Stiefelhagen, P | 3 |
| Jim, MH; Wong, KL; Yiu, KH | 1 |
| Akasaka, T; Arima, Y; Hokimoto, S; Kaikita, K; Kumagae, N; Morita, K; Nakagawa, K; Ogawa, H; Oniki, K; Sakamoto, K; Tabata, N; Tsujita, K; Yamamoto, E | 1 |
| Adamo, M; Costa, F; Garcia-Garcia, HM; Leonardi, S; Navarese, EP; Valgimigli, M; Vranckx, P | 1 |
| Aksenova, MG; Chernyi, OV; Dobrovolsky, AV; Kopylov, FY; Lomakin, OV; Mesitskaya, DF; Nikitina, YM | 1 |
| Capranzano, P; Castiglioni, B | 1 |
| Kioufis, S; Kokkou, E; Mourouzis, K; Oikonomou, E; Papavassiliou, AG; Siasos, G; Stone, PH; Tousoulis, D; Vavuranakis, M; Vlasis, K; Zaromitidou, M | 1 |
| Che, JJ; Chen, KY; Li, GP; Liu, T; Rha, SW; Xu, LX; Zheng, XT | 1 |
| Brodie, BR; Cox, DA; Duffy, PL; Généreux, P; Henry, TD; Kirtane, AJ; Maehara, A; Mazzaferri, EL; Mehran, R; Metzger, DC; Neumann, FJ; Parikh, PB; Parvataneni, R; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Xu, K | 1 |
| Chen, J; Gao, RL; He, C; Liu, R; Ma, YL; Meng, XM; Song, L; Song, Y; Tang, XF; Wang, M; Xu, B; Xu, JJ; Yao, Y; Yuan, JQ; Zhang, JH | 1 |
| Berger, JS; Smilowitz, NR | 1 |
| Du, M; Ma, G; Shi, Y; Zhang, D | 1 |
| Bockeria, OL; Donakanyan, SA; Koasari, AK; Kudzoeva, ZF; Shvarts, VA | 1 |
| He, Y; Jin, L; Li, A; Liu, B; Ou, W | 1 |
| Chae, IH; Cho, YS; Choi, DJ; Kang, SH; Kim, HS; Kim, YG; Park, JJ; Suh, JW; Yoon, CH; Youn, TJ | 1 |
| Chen, JY; He, GD; Li, HP; Li, XX; Lin, HM; Liu, JE; Meng, JX; Tang, L; Tang, QJ; Wang, LY; Wu, H; Zhang, MZ; Zhong, SL; Zhong, WP | 1 |
| Chen, Y; Gao, CY; Yang, HH | 1 |
| Chen, JY; He, GD; Lei, HP; Li, HP; Li, XX; Lin, HM; Liu, SW; Ma, DL; Mai, LP; Sun, S; Tang, L; Wang, XP; Wu, H; Zhang, B; Zhang, ZW; Zhong, SL; Zhong, WP; Zhou, HK | 1 |
| López-Higueras, A; Martínez-Andrés, B; Pérez-Cuadrado-Martínez, E; Pérez-Cuadrado-Robles, E; Quesada-Vázquez, N; Rubio-Mateos, JM; Sánchez-Melgarejo, JF | 1 |
| Amann, M; Bömicke, T; Ferenc, M; Hauschke, D; Hochholzer, W; Kleiner, P; Löffelhardt, N; Neumann, FJ; Stratz, C; Trenk, D; Valina, CM; Younas, I | 1 |
| Haag, E; Lee, MS; Pollack, S; Reichek, N; Santiago, L; Shlofmitz, E; Shlofmitz, RA | 1 |
| Colás, C; Cubero, JL; Millán, P; Simó Sánchez, B | 1 |
| Barbato, E; Geene, SMC; Janssen, PWA; Mol, EA; Ten Berg, JM | 1 |
| Chang, CM; Chu, WM; Lam, KF; Lau, YK; Ng, FH; Wong, BC; Wong, SY; Yuen, WC | 1 |
| Ferro, A; Jackson, G; Ji, Y; O'Kane, PD; Reebye, V; Stratton, P | 1 |
| Angiolillo, DJ; Bass, TA; Guzman, LA | 1 |
| Barnett, PG; Boden, WE; Bowen, J; Deaton, C; Dunbar, SB; Goeree, R; Hartigan, PM; Jurkovitz, C; Kaufman, S; Kolm, P; Lewis, C; Mancini, GB; Maron, DJ; O'Rourke, RA; Spertus, JA; Teo, KK; Veledar, E; Weintraub, WS; Zhang, W; Zhang, Z | 1 |
| Alberts, MJ | 1 |
| Aĭnetdinova, DKh; Sulimov, VA; Udovichenko, AE | 1 |
| Asano, T; Fukushima, K; Ishio, N; Iwata, Y; Kitahara, H; Kobayashi, Y; Komuro, I; Kuroda, N | 1 |
| Hohlfeld, T; Zimmermann, N | 1 |
| Berger, PB; Braun, S; Byrne, RA; Iijima, R; Kastrati, A; Mehilli, J; Ndrepepa, G; Schömig, A | 1 |
| Chan, P; Cheung, TK; Kng, C; Kwanching, CP; Lai, ST; Loo, CK; Ng, FH; Ng, KM; Wong, BC; Wong, SY | 1 |
| Bond, SP; Buerke, M; Faerber, J; Maegdefessel, L; Messow, CM; Muenzel, T; Raaz, U; Schlitt, A; Weiss, C; Werdan, K | 1 |
| Goto, S; Serebruany, VL | 1 |
| Arnesen, H; Budaj, A; De Caterina, R; Filipiak, K; Golanski, J; Gorski, J; Huber, K; Kristensen, SD; Kuliczkowski, W; Opolski, G; Polonski, L; Pregowski, J; Sitkiewicz, D; Watala, C; Witkowski, A; Zembala, M | 1 |
| Dörrler, K; Kastrati, A; Koch, W; Latz, W; Mehilli, J; Morath, T; Schömig, A; Sibbing, D; Stegherr, J; von Beckerath, N | 1 |
| Bhatt, DL; Fox, KA; Haffner, SM; Hamm, CW; Hankey, GJ; Johnston, SC; Mak, KH; Montalescot, G; Shao, M; Steg, PG; Steinhubl, SR; Topol, EJ | 1 |
| Choi, BR; Hwang, JY; Jeong, YH; Kim, IS; Kwak, CH; Lee, SW; Park, SW; Seo, MK | 1 |
| Liu, J; Liu, Q; Niu, S; Smith, SC; Wang, W; Zhao, D; Zhu, J | 1 |
| Antoniades, C; Briasoulis, A; Dhamrait, SS; Stefanadis, C; Tousoulis, D | 1 |
| Barker, CM; Kandzari, DE; Nayak, KR; Price, MJ; Teirstein, PS | 1 |
| Brandt, JT; Braun, OO; Close, SL; Erlinge, D; James, S; Man, M; Siegbahn, A; Varenhorst, C; Walker, J; Wallentin, L; Winters, KJ | 1 |
| Alfonso, F; Angel, J; Bueno, H; Fernández-Avilés, F; Ferreira-González, I; García-Dorado, D; López-Minguez, JR; Mainar, V; Maristany, J; Prendergast, B; Rodríguez, O; Sambola, A; San Román, A; Tornos, P; Zueco, J | 1 |
| Fuller, M; Misra, S; Muldowney, JA; Pecot, CV | 1 |
| Eriksson, AC; Hedbäck, B; Jonasson, L; Lindahl, TL; Whiss, PA | 1 |
| Boura, J; Harjai, KJ; Orshaw, P; Shenoy, C | 1 |
| Cheng, WJ; Ge, HL; Guo, YH; Jia, DA; Liu, YY; Nie, B; Shi, DM; Wang, ZJ; Yan, ZX; Yang, SW; Yu, M; Zhao, YX; Zhou, YJ | 1 |
| Berenson, K; Casciano, R; Corbelli, J; Lamerato, L; Makenbaeva, D; Mozaffari, E; Stern, L; Wiederkehr, D | 1 |
| Casciano, R; Corbelli, J; Makenbaeva, D; Mozaffari, E; Ogbonnaya, A; Wiederkehr, D | 1 |
| Guyer, KE | 1 |
| Fernandez-Pereira, C; Llaurado, C; Mieres, J; Perez, G; Risau, G; Rodriguez, AE; Rodriguez-Granillo, AM; Rubilar, B | 1 |
| Ak, K; Arsan, S; Eksioglu-Demiralp, E; Iqbal, O; Isbir, S; Tetik, S; Yardimci, T | 1 |
| Asano, F; Endo, Y; Inoue, K; Sawada, S; Takeyama, Y; Yamada, M; Yasuda, H; Yoshiba, M | 1 |
| Akin, I; Chatterjee, A; Chatterjee, T; Ince, H; Nienaber, CA; Rehders, TC; Schüpfer, C | 1 |
| Klauss, V; Krötz, F; Nagel, J; Schuhmann, CG; Sohn, HY; Spannagl, M | 1 |
| Goto, S; Toda, E | 1 |
| Gawaz, M; Geisler, T | 1 |
| Gurbel, PA; Tantry, US | 1 |
| Armero, S; Arques, S; Bonello, C; Bonello, L; Bonello-Palot, N; Camoin-Jau, L; Dignat-George, F; Mokhtar, OA; Paganelli, F | 1 |
| Bouman, HJ; Breet, NJ; de Boer, A; Deneer, VH; Hackeng, CM; Harmsze, A; Klungel, OH; Ruven, HJ; Ten Berg, JM; Tjoeng, MM; van Werkum, JW | 1 |
| Danenberg, HD; Lotan, C; Marincheva, G; Nassar, H; Varshitzki, B | 1 |
| Dorsch, MP; Momary, KM | 1 |
| Berger, PB | 2 |
| Chae, JK; Cheong, SS; Choi, YJ; Chung, WS; Han, KH; Hur, SH; Jang, JS; Jeon, DS; Jeong, MH; Kang, SJ; Kim, KS; Kim, YH; Lee, BK; Lee, CW; Lee, K; Lee, NH; Lee, SG; Lee, SW; Lim, DS; Nah, DY; Park, DW; Park, HS; Park, SJ; Park, SW; Rha, SW; Seong, IW; Seung, KB; Yang, JY; Yoon, J; Yun, SC | 1 |
| Chotinaiwattarakul, C; Lerdwilai, T; Panchavinnin, P; Phankingthongkum, R; Pornratanarangsi, S; Sudjaritruk, S; Tresukosol, D; Tungsubutra, W; Wongpraparat, N | 1 |
| Dixon, SR; Grines, CL; O'Neill, WW | 1 |
| Damani, SB; Topol, EJ | 1 |
| Shen, WF | 1 |
| Chen, J; Chen, JL; Dai, J; Gao, LJ; Gao, RL; Huang, JH; Li, JJ; Liu, HB; Qiao, SB; Qin, XW; Wu, YJ; Xu, B; Yang, YJ; Yao, M; You, SJ; Yuan, JQ | 1 |
| Bliden, KP; Butler, K; Ecob, R; Gurbel, PA; Karunakaran, A; Patil, SB; Storey, RF; Tantry, US; Teng, R; Wei, C | 1 |
| Okura, H | 1 |
| Adamczak, M; Boulesteix, AL; Eifert, S; Kilian, E; Lamm, P; Mair, H; Reichart, B | 1 |
| Memtsoudis, SG; Sharrock, NE | 1 |
| Rennings, AJ; Schouwenberg, BJ; van Onzenoort, HA | 1 |
| Dandel, M; Hetzer, R; Knosalla, C | 1 |
| Cai, J; Fan, L; Liu, CF; Sun, J; Wang, ZG; Wu, Q | 1 |
| Arcozzi, C; Borghesi, M; Campo, G; Cangiano, E; Cavazza, C; Colombo, F; Ferrari, F; Ferrari, R; Frangione, A; Kubbajeh, M; Marchesini, J; Minarelli, M; Monti, M; Parrinello, G; Percoco, G; Scalone, A; Tebaldi, M; Tumscitz, C; Valgimigli, M; Zuffi, A | 1 |
| Menown, IB | 1 |
| Abe, T; Chitose, T; Deguchi, M; Hokimoto, S; Kaikita, K; Miyagawa, H; Morita, K; Nakagawa, K; Ogawa, H; Ono, T; Saruwatari, J; Sugiyama, S; Sumida, H; Tsujita, K; Yamamoto, K | 1 |
| Bouman, HJ; Hackeng, CM; Hirschhäuser, C; Schmalz, HG; Schömig, E; Taubert, D; ten Berg, JM; van Werkum, JW; Velder, J; Waldmann, C | 1 |
| Ara, R; Cooper, K; Fairbank, E; Palmer, S; Raftery, J; Turner, D; Ward, S | 1 |
| Bae, JH; Bae, JW; Chae, IH; Cho, MC; Cho, YS; Choi, DJ; Kang, HJ; Kim, HS; Koo, BK; Kwon, TG; Lee, HY; Lee, SP; Park, KW; Rha, SW; Suh, JW; Youn, TJ | 1 |
| Banerjee, S; Bhatt, DL; Brilakis, ES; Cryer, B; de Lemos, JA; Gunter, JT; Kastrati, A; Kelly, KC; Little, BB; Rao, SV; Reilly, RF; Shank, M; Tortorice, KL; Weideman, MW; Weideman, RA | 1 |
| Alvarez-Contreras, L; Brugaletta, S; Cola, C; de Antonio, M; Ferreira-González, I; García-Picart, J; Martí, V; Martin-Yuste, V; Sabaté, M | 1 |
| Hamm, CW; Rassaf, T | 1 |
| Ebina, T; Endo, M; Hibi, K; Iwahashi, N; Kimura, K; Kosuge, M; Maejima, N; Morita, S; Sugano, T; Tsukahara, K; Umemura, S | 1 |
| Angiolillo, DJ; Bates, ER; Lau, WC | 1 |
| Sharma, JC; Sharma, N | 1 |
| Bernlochner, I; Byrne, RA; Kastrati, A; Koch, W; Massberg, S; Mayer, K; Mehilli, J; Schömig, A; Schulz, S; Sibbing, D | 1 |
| Fearon, WF; Hunt, SA; Ikeno, F; Lee, DP; Ng, MK; Tremmel, JA; Yeung, AC | 1 |
| Cho, YK; Hong, GR; Hur, SH; Jang, JS; Kim, DI; Kim, DK; Kim, DS; Kim, KB; Kim, U; Kim, YJ; Nam, CW; Park, JS; Seol, SH; Shin, DG; Yang, TH | 1 |
| Choi, JW; Farkouh, ME; Kim, MC; Mann, DM; Muntner, P; Shimbo, D; Stoler, RC; Woodward, M | 1 |
| Gaglia, MA; Kent, KM; Mahmoudi, M; Pakala, R; Pichard, AD; Sardi, G; Satler, LF; Suddath, WO; Torguson, R; Waksman, R; Xue, Z | 1 |
| Choi, YJ; Gwak, CH; Hong, SJ; Joo, SJ; Kim, HS; Kim, KS; Kim, SH; Park, TH; Seung, KB; Suh, JW; Tahk, SJ | 1 |
| Chen, J; Chen, JL; Chen, ZJ; Dai, J; Gao, RL; He, C; Li, JJ; Liu, HB; Meng, XM; Qiao, SB; Qin, XW; Tang, XF; Wu, Y; Wu, YJ; Yang, YJ; Yao, M; You, SJ; Yuan, JQ | 1 |
| Chitose, T; Fujimoto, K; Hirose, T; Hokimoto, S; Kaikita, K; Maruyama, H; Miyao, Y; Mizobe, M; Nakamura, S; Nakao, K; Ogawa, H; Oshima, S; Shimomura, H; Tsunoda, R; Yamamoto, K | 1 |
| Jeger, R; Kaiser, C; Pfisterer, M | 1 |
| Ahn, T; Chae, IH; Choi, JH; Choi, SH; Choi, YJ; Chung, WY; Gwon, HC; Hahn, JY; Han, KR; Hong, TJ; Hur, SH; Jang, Y; Jeon, DW; Jeon, HK; Jeong, MH; Kang, HJ; Kim, BO; Kim, HS; Koo, BK; Kwon, HM; Lee, NH; Lim, DS; Park, KW; Park, SH; Song, YB; Yoon, JH | 1 |
| Dong, CM; Jia, XQ; Qin, J; Zhang, L | 1 |
| Barbosa, SP; Bianco, HT; Fonseca, FA; França, CN; Izar, MC; Kasmas, SH; Mendes, GD; Pinheiro, LF; Povoa, RM | 1 |
| Azcona, L; Jiménez Mateos-Cáceres, P; López Farré, AJ; Macaya, C; Modrego, J; Rodríguez, P; Segura, A; Zamorano-León, JJ | 1 |
| Angiolillo, DJ; Baker, BA; Heiselman, DE; Jakubowski, JA; Li, W; Logan, DK; Price, MJ; Walder, JS; Winters, KJ | 1 |
| Pakhomov, IaM | 1 |
| Cherala, G; Ganesan, S; Maslen, CL; Williams, C | 1 |
| Abtan, J; Aubry, P; Barthélémy, O; Belle, L; Beygui, F; Boueri, Z; Carrié, D; Cayla, G; Collet, JP; Cuisset, T; Elhadad, S; Henry, P; Kerneis, M; Monségu, J; Montalescot, G; Motreff, P; O'Connor, SA; Pouillot, C; Rangé, G; Rousseau, H; Sabouret, P; Saint-Etienne, C; Silvain, J; Van Belle, E; Vicaut, E | 1 |
| Bobbert, P; Bobbert, T; Rauch, U; Schultheiss, HP; Schütte, C; Steffens, D; Stellbaum, C | 1 |
| Armbruster, S; Mann, J; Schepp, W; Schneider, AR; Schuster, T; von Römer, W | 1 |
| Brindis, R; Go, AS; Hlatky, MA; Leong, TK; Shilane, D; Solomon, MD | 1 |
| Bonz, AW; Ertl, G; Harre, K; Held, S; Kochsiek, N; Lengenfelder, B; Meesmann, M; Neyses, L; Schanzenbächer, P; Strotmann, J; Turschner, O; Voelker, W; Wacker, C; Waller, C | 1 |
| Turpie, AG | 1 |
| Cannon, CP | 1 |
| Budaj, A; Chrolavicius, S; Fox, KA; Franzosi, MG; Hunt, D; Keltai, M; Mehta, SR; Tognoni, G; Yusuf, S; Zhao, F | 1 |
| SoRelle, R | 1 |
| Fitzgerald, D; McRedmond, J | 1 |
| Budaj, A; Copland, I; Eikelboom, JW; Johnston, M; Maciejewski, P; Weitz, JI; Yusuf, S; Zhao, F | 1 |
| Fitchett, D; Goodman, SG; Gupta, M; Langer, A | 1 |
| Fox, KA; Otterstad, JE | 1 |
| Alt, E; Maca, T; Minar, E; Schneider, B; Speiser, W; Ziegler, S | 1 |
| Jagroop, IA; Mikhailidis, DP | 1 |
| Fischer, TC; Groneberg, DA; Worm, M | 1 |
| Pollack, CV | 1 |
| Atmaca, Y; Dandachi, R; Dincer, I; Gülec, S; Oral, D | 1 |
| Akinlade, BK | 1 |
| de Lemos, JA; McGuire, DK | 1 |
| Armstrong, EC | 1 |
| Ramsey, SD | 1 |
| Yaes, RJ | 1 |
| Alford, AB; Bell, CR; Cummings, CC; Gurbel, PA; Meister, AF; Serebruany, VL | 1 |
| Andrié, R; Bauriedel, G; Jabs, A; Lüderitz, B; Schneider, M; Skowasch, D | 1 |
| Albiero, R; Colombo, A; Corvaja, N; Di Mario, C; Falotico, R; Stankovic, G; Takagi, T; Toutouzas, K | 1 |
| Bowen, J; Cubeddu, G; Cubeddu, RJ; Jobe, RL; Mann, T; Newman, W; Raynor, L; Raza, JA; Rose, G; Schneider, JE; Zellinger, M | 1 |
| Dardas, PS; Mezilis, NE; Styliadis, G; Tsikaderis, DD | 1 |
| Bhatt, DL; Gerschutz, GP | 1 |
| Lecompte, T | 1 |
| Choi, D; Ho, DS; Hong, MK; Jang, Y; Lam, R; Lee, CW; Mintz, GS; Park, SJ; Park, SW; Raizner, AE; Shim, WH; Weissman, NJ | 1 |
| Bliden, KP; Gurbel, PA | 1 |
| Bartolozzi, JJ; Price, WF; Sauls, FC | 1 |
| Badimon, JJ; Bhatt, DL; Corti, R; Francis, GS; Fuster, V; Jneid, H | 1 |
| Berger, P; Steinhubl, S | 1 |
| Moliterno, DJ; Saw, J | 1 |
| Bertel, O; Genoni, M; Hofer, C; Tavakoli, R; Turina, M | 1 |
| Bossaller, C; Gitt, AK; Heer, T; Juenger, C; Limbourg, P; Meisenzahl, C; Schiele, R; Senges, J; Wienbergen, H | 1 |
| Averkov, OV; Dobrovol'skiĭ, AB; Gratsianskiĭ, NA; Slavina, NN | 1 |
| Gulba, DC; Lankes, W | 1 |
| Gersh, BJ; Holmes, DR; Mathew, V; Prasad, A | 1 |
| Sánchez-Delgado, E | 1 |
| Gratsianskiĭ, NA | 2 |
| Akkus, MN; Camsari, A; Cicek, D; Cin, VG; Doven, O; Parmaksiz, T; Pekdemir, H | 1 |
| Fernandez, JS; Sadaniantz, A; Sadaniantz, BT | 1 |
| Knight, CJ | 1 |
| Pieper, JA; Wodlinger, AM | 1 |
| Barry, WH; Coletti, AT; Jessup, DB; Muhlestein, JB; Shean, FC; Whisenant, BK | 1 |
| Günesdogan, B; Hanefeld, C; Mügge, A; Neubauer, H; Spiecker, M | 1 |
| Hansen, O | 1 |
| Besta, F; Gawaz, M; Massberg, S; Mueller, I; Thomas, P | 1 |
| Lip, GY; Tan, KT | 1 |
| Bahrmann, P; Emig, U; Figulla, HR; Mutschke, O; Schwarz, G; Werner, GS | 1 |
| Knowles, SR; Phillips, EJ; Shear, NH | 1 |
| Bracchetti, D; Casella, G; Fontanelli, A; Galvani, M; Ottani, F; Pavesi, PC; Rubboli, A; Sangiorgio, P | 1 |
| Berger, PB; Bollwein, H; Dirschinger, J; Dotzer, F; Gawaz, M; Kastrati, A; Mehilli, J; Neumann, FJ; Schömig, A; Schühlen, H; ten Berg, JM; Volmer, C | 1 |
| Hillis, LD; Lange, RA | 1 |
| Beygui, F; Borentain, M; Choussat, R; Collet, JP; Montalescot, G | 1 |
| Saw, J; Topol, EJ | 1 |
| Becker, RC; Spencer, FA | 1 |
| Berger, PB; Burger, K; Fasseas, P; Holmes, DR; Melby, S; Orford, JL; Steinhubl, SR | 1 |
| Eikelboom, JW; Hankey, GJ; Ho, WK | 1 |
| Alhan, C; Evrenkaya, S; Goksel, O; Karabulut, H; Tarcan, S; Toraman, F | 1 |
| Elisaf, M; Goudevenos, JA; Mitsios, JV; Papathanasiou, AI; Rodis, FI; Tselepis, AD | 1 |
| Heikkilä, J; Lassila, R; Lepäntalo, A; Virtanen, KS; Wartiovaara, U | 1 |
| Jönsson, B; Lindgren, P; Yusuf, S | 1 |
| Guillory, GS; Jain, SP; Manor, SM | 1 |
| Helø, OH; Kastrup, J; Madsen, JK | 1 |
| Gitt, AK; Gottwik, M; Heer, T; Juenger, C; Schiele, R; Senges, J; Vogel, C; Wienbergen, H | 1 |
| Abbate, A; Agostoni, P; Biasucci, LM; Biondi-Zoccai, GG; Burzotta, F; Mongiardo, R; Parisi, Q; Testa, L; Trani, C; Vassanelli, C | 1 |
| Angiolillo, DJ; Bernardo, E; Escaned, J; Fernandez-Ortiz, A; Hernández-Antolin, R; Macaya, C; Moreno, R; Pignatti, PF; Ramírez, C; Sabaté, M; Trabetti, E | 1 |
| Antman, EM; Wiviott, SD | 1 |
| Genest, M; Pochmalicki, G | 1 |
| Kiemeneij, F; Laarman, GJ; Riezebos, RK; Slagboom, T; van der Heijden, DJ; van der Wieken, LR; Westendorp, IC | 1 |
| Stadius, ML | 1 |
| Gorchakova, O; Joost, A; Kastrati, A; Pogatsa-Murray, G; Schömig, A; von Beckerath, N | 1 |
| Bhatt, DL; Chan, AW; Chew, DP; Ellis, SG; Moliterno, DJ; Topol, EJ; Vivekananthan, DP; Zidar, FJ | 1 |
| Koh, TW | 1 |
| Kerr, JL; Oppelt, TF; Rowen, RC | 1 |
| Betriu, A; DeSmet, W; Kleiman, NS; Lincoff, AM; Rutsch, W; Saw, J; Topol, EJ; Wilcox, RG; Wolski, K | 1 |
| Dalen, JE; Gutterman, D; Schünemann, HJ; Stein, PD | 1 |
| Griffin, S; Hawkins, N; Henderson, R; Jones, L; Main, C; Orton, V; Palmer, S; Riemsma, R; Sculpher, M; Sudlow, C | 1 |
| Kapilevich, NA; Kisteneva, IV; Markov, VA; Novitskiĭ, VV; Poponina, TM | 1 |
| Boonstra, PW; van Oeveren, W | 1 |
| Berger, PB; Bollwein, H; Dirschinger, J; Dotzer, F; Kandzari, DE; Kastrati, A; Mehilli, J; Neumann, FJ; Schömig, A; Steinhubl, SR; Ten Berg, JM | 1 |
| Bosmans, JM; Claeys, MJ; Michiels, JJ; Van Der Goten, P; Van der Planken, MG; Vertessen, F; Vrints, CJ; Wuyts, FL | 1 |
| Bhatt, DL; Rajagopal, V | 1 |
| Davis, KE; Denardo, SJ; Tcheng, JE | 1 |
| Ball, SP; Barnard, MR; Fox, ML; Frelinger, AL; Furman, MI; Krueger, LA; Linden, MD; Michelson, AD | 1 |
| Hölschermann, H | 1 |
| Bafi, AS; Boyce, SW; Corso, PJ; Dullum, MK; Haile, E; Hill, PC; Kapetanakis, EI; Medlam, DA; Petro, KR | 1 |
| Jönsson, B; Lindgren, P; Malmberg, K; Stenestrand, U | 1 |
| Caro, J; Culler, S; Gabriel, S; Lamy, A; Mahoney, EM; Weintraub, WS; Yuan, Y; Yusuf, S | 1 |
| Cuthill, JA; Greer, IA; Oldroyd, K; Young, S | 1 |
| Eichinger, M; Kastrati, A; Koch, W; Schömig, A; von Beckerath, N; von Beckerath, O | 1 |
| Baysan, O; Erinc, K; Isik, E; Ozkan, M; Sag, C; Uzun, M; Yokusoglu, M | 1 |
| Abdelnoor, M; Arnesen, H; Pettersen, AA; Seljeflot, I | 1 |
| De Caterina, R; Renda, G; Zimarino, M | 1 |
| Behan, MW; Fox, SC; Heptinstall, S; Storey, RF | 1 |
| Kunz, I; Ruggieri, F; Spada, S; Sütsch, G | 1 |
| Dörffler-Melly, J; Haeberli, A; Hess, OM; Imboden, K; Meier, B; Togni, M; Wenaweser, P; Windecker, S | 1 |
| Ajzenberg, N; Aubry, P; Baruch, D; Cachier, A; El Amara, W; Feldman, LJ; Guillin, MC; Himbert, D; Huisse, MG; Steg, PG | 1 |
| Elsässer, A; Hamm, CW; Möllmann, H; Nef, H | 1 |
| Gluckman, TJ; Rade, JJ; Schulman, SP | 1 |
| Guthikonda, S; Kleiman, NS; Lev, EI | 1 |
| Brosteanu, O; Busch, I; Niebauer, J; Schuler, G; Sick, PB; Thiele, H; Ulrich, M | 1 |
| Elisaf, M; Goudevenos, JA; Mitsios, JV; Papathanasiou, AI; Tselepis, AD | 1 |
| Akehurst, R; Bakhai, A; Brennan, A; Flather, M; Gray, D; Karnon, J; Pandor, A; Warren, E | 1 |
| Almsherqi, Z; Deng, Y; McLachlan, C; Mossop, PJ | 1 |
| Alfonso, F; Angiolillo, DJ; Bañuelos, C; Bass, TA; Bernardo, E; Costa, MA; Escaned, J; Fernandez-Ortiz, A; Hernández, R; Jimenez-Quevedo, P; Macaya, C; Moreno, R; Ramírez, C; Sabaté, M | 2 |
| Doggrell, SA | 2 |
| Amit, G; Cafri, C; Gilutz, H; Ilia, R; Wolak, A; Zahger, D | 1 |
| Adgey, AA; Crossman, D; Spence, MS; Walsh, SJ | 1 |
| Hacke, W | 1 |
| Berger, PB; Bhatt, DL; Black, HR; Boden, WE; Booth, J; Cacoub, P; Cohen, EA; Creager, MA; Easton, JD; Flather, MD; Fox, KA; Hacke, W; Haffner, SM; Hamm, CW; Hankey, GJ; Johnston, SC; Mak, KH; Mas, JL; Montalescot, G; Pearson, TA; Steg, PG; Steinhubl, SR; Topol, EJ; Weber, MA | 1 |
| Armstrong, M; Dupont, A; Gaussem, P; Judge, HM; Peters, G; Smith, SM; Storey, RF | 1 |
| Chen, WH; Kaul, U; Lam, KF; Lau, CP; Lau, YK; Lee, MK; Lee, PY; Leung, AW; Leung, SK; Li, SK; Ng, W; Tan, HC; Tse, HF | 1 |
| Begg, EJ; Bridgman, P; Doogue, MP | 1 |
| Alfonso, F; Angiolillo, DJ; Bañuelos, C; Bass, TA; Bernardo, E; Cavallari, U; Costa, MA; Escaned, J; Fernandez-Ortiz, A; Hernández, R; Jimenez-Quevedo, P; Macaya, C; Moreno, R; Pignatti, PF; Ramírez, C; Sabaté, M; Trabetti, E | 1 |
| Chan, WK; Chau, TN; Lai, ST; Leung, MF; Leung, VK; Mok, NS; Yim, KF | 1 |
| Herbison, P; Kay, P; Restieaux, N; Tang, E; Wilkins, G; Williams, M; Wong, CK | 1 |
| Boulman, N; Rosner, I; Rozenbaum, M; Slobodin, G | 1 |
| Kastrati, A; Pogatsa-Murray, G; Schömig, A; Schömig, E; Taubert, D; von Beckerath, N | 1 |
| Leslie, SJ; Soiza, RL | 1 |
| Bull, S; Chahal, N; McKenna, CJ | 1 |
| Han, KH; Hong, MK; Kang, DH; Kim, JJ; Kim, YH; Lee, BK; Lee, CW; Lee, SW; Park, SJ; Park, SW; Song, JK; Song, JM | 1 |
| Behar, S; Gottlieb, S; Hammerman, H; Hasdai, D; Hod, H; Iakobishvili, Z; Konstantino, Y; Porter, A; Sandach, A; Zahger, D | 1 |
| Al Suwaidi, J; Salam, AM | 1 |
| Bert, A; Maslow, A; Ng, T | 1 |
| Din, JN; Fox, KA | 1 |
| Budaj, A; Fox, KA; Halon, DA; Keltai, M; Lewis, BS; Mehta, SR; Peters, RJ; Yusuf, S; Zhao, F | 1 |
| Alessi, MC; Barbou, F; Bonnet, JL; Cuisset, T; Frere, C; Hovasse, T; Morange, PE; Quilici, J | 1 |
| Bhatt, DL; Brogan, GX; Farkouh, ME; Gibler, WB; Mulgund, J; Ohman, EM; Peterson, ED; Pollack, CV; Roe, MT | 1 |
| Filipiak, KJ; Glowczynska, R; Grabowski, M; Kisiel, B; Kochman, J; Kostrzewa, G; Malek, LA; Opolski, G; Ploski, R; Spiewak, M | 1 |
| Aytac, A; Cui, H; Gurbuz, AT; Vuran, AC; Zia, AA | 1 |
| Heptinstall, S | 1 |
| Dokainish, H; Gonzales, R; Gonzalez, R; Lakkis, N; Patel, P | 1 |
| Giannitsis, E; Ivandic, BT; Katus, HA; Kurz, K; Schlick, P; Staritz, P | 1 |
| Ahrens, I; Bode, C; Klaus, T | 1 |
| Galvani, M | 1 |
| Mitsudo, K | 1 |
| Agostoni, P; Airoldi, F; Antoniucci, D; Biondi-Zoccai, GG; Chieffo, A; Colombo, A; Cosgrave, J; Di Mario, C; Goktekin, O; Grube, E; Iakovou, I; Michev, I; Reimers, B; Sangiorgi, GM; Tamburino, C; Tassanawiwat, W | 1 |
| Demirtaş, E; Ide, T; Işik, E; Iyisoy, A; Köz, C; Kurşaklioğlu, H; Töre, HF; Yildirim, V | 1 |
| Berge, C; Deme, M; Gershlick, AH; Guagliumi, G; Guyon, P; Lotan, C; Schofer, J; Seth, A; Sousa, JE; Stoll, HP; Urban, P; Wijns, W | 1 |
| Chen, YD; Jin, ZN; Lü, SZ; Lu, YL; Yuan, F | 1 |
| Atar, D; Defranco, A; Mahmud, E; Malinin, A; Pokov, A; Schwartz, D; Schwartz, K; Serebruany, V; Spergling, M | 1 |
| Bavry, AA; Lincoff, AM | 1 |
| Chetty, N; Munster, M; Naran, NH | 1 |
| Macdonald, J; More, R; Srinivasan, M | 1 |
| Lowry, DR; Malinin, AI; Meilman, H; Midei, MG; Serebruany, VL | 1 |
| Han, YL; Jing, QM; Li, Y; Luan, B; Ma, YY; Su, QF; Wang, DM; Wang, SL; Wang, ZL | 1 |
| Lyseng-Williamson, KA; Plosker, GL | 1 |
| Cofta, S; Elikowski, W; Mańczak, J; Nowicki, A; Psuja, P | 1 |
| Fasano, MB; Horwitz, PA; Walker, NE | 1 |
| Kreindel, M; Lincoff, AM; Patel, TN | 1 |
| Coolong, A; Mauri, L | 1 |
| Davì, G; Santilli, F | 1 |
| Grayson, AD; Lowe, R; Moore, RK; Morris, JL; Perry, RA; Stables, RH | 1 |
| Abgrall, JF; Arnaud, B; Boschat, J; Gilard, M; Le Gal, G | 1 |
| Angiolillo, DJ | 2 |
| Haghfelt, TH; Heeg, B; Hout, Bv; Olsen, J; van Gestel, A | 1 |
| Antman, EM; Braunwald, E; Gibson, CM; McCabe, CH; Montalescot, G; Riesmeyer, J; Warmke, JW; Weerakkody, G; Winters, KJ; Wiviott, SD | 1 |
| Frossard, M; Fuchs, I; Jilma, B; Laggner, AN; Riedmüller, E; Spiel, A | 1 |
| Feit, F; Yehudai, L | 1 |
| Kristensen, SD | 1 |
| Cooke, GE; Goldschmidt-Clermont, PJ | 1 |
| Bromberg-Marin, G; Canto, JG; Marin-Neto, JA; Parsons, LS; Rogers, WJ | 1 |
| Arnesen, H; Pettersen, AA; Seljeflot, I; Solheim, S | 1 |
| Gurbel, PA; Tantry, US; Wiviott, SD | 1 |
| Chan, WK; Lee, KK; Lee, VW | 1 |
| Bliden, KP; Gurbel, PA; Tantry, US | 1 |
| Münzel, TF; Post, F | 1 |
| Baim, DS; Brinster, DR; Byrne, M; Cohn, LH; Couper, GS; Rogers, CD; Simon, DI | 1 |
| Brennan, D; Francis, GS; Maroo, A; McErlean, E; Steinhubl, SR; Tang, WH; Topol, EJ; Van Lente, F | 1 |
| Alviar, CL; Arikan, ME; Dave, BP; DeLao, T; Granada, JF; Kleiman, NS; Lev, EI; Maresh, K; Tellez, A | 1 |
| Badimon, JJ; Choi, BG; Fuster, V; Vilahur, G; Viles-Gonzalez, JF; Vorchheimer, DA; Zafar, MU | 1 |
| Ang, CK; Chin, SP; Fong, YY; Gudum, HR; Liew, CK; Liew, HB; Ong, TK; Rapaee, A; Sim, KH; Tay, SP | 1 |
| Anders, N; Gawaz, M; Geisler, T; Herdeg, C; Langer, H; Lindemann, S; May, AE; Paterok, M; Stellos, K | 1 |
| Dániel, A; Horváth, IG; Komócsi, A; Pintér, T | 1 |
| Filipiak, KJ; Grabowski, M; Główczyńska, R; Huczek, Z; Imiela, T; Małek, ŁA; Opolski, G; Rosiak, M; Spiewak, M; Szpotańska, M | 1 |
| Donovan, JL; Gandhi, PJ; Silva, MA; Volturo, GA | 1 |
| Hamilos, MI; Kochiadakis, GE; Vardas, PE; Vavouranakis, I | 1 |
| Hamdalla, H; Steinhubl, SR | 1 |
| Liao, JK | 1 |
| Sureddi, RK | 1 |
| Bartorelli, AL; Benassi, A; Chierchia, S; Di Mario, C; Galassi, A; Piovaccari, G; Reimers, B; Sangiorgio, P; Serdoz, R; Sheiban, I; Tamburino, C; Trabattoni, D; Zimarino, M | 1 |
| Hawken, S; Keltai, M; Lewis, BS; Mann, JF; Mehta, SR; Sitkei, E; Tonelli, M; Yusuf, S | 1 |
| Adnet, F; Catineau, J; Lapandry, C; Lapostolle, F | 1 |
| Fefer, P; Hod, H; Matetzky, S | 1 |
| Spinler, SA | 1 |
| Kay, P; Tie, S; Wilkins, G; Williams, M; Wong, CK; Yap, J | 1 |
| Gladding, P; Webster, M | 1 |
| Alison, P; Sidebotham, D | 1 |
| Agostoni, P; Andreotti, F; Crea, F; Porto, I; Testa, L; Trotta, G; Zoccai, GB | 1 |
| Erdmann, E; Hoppe, UC | 1 |
| Chow, G; Ziegelstein, RC | 1 |
| Collins, JS; Gurm, HS | 1 |
| Roe, MT; Steinhubl, S | 1 |
| Mak, KH | 1 |
| Rupprecht, HJ | 1 |
| Choi, D; Jang, Y; Jung, JH; Ko, YG; Min, PK; Shim, WH | 1 |
| Becker, RC; Gurbel, PA; Mann, KG; Michelson, AD; Steinhubl, SR | 1 |
| Atar, D; Frasure-Smith, N; Laliberté, MA; Lespérance, F; Malinin, AI; Serebruany, VL; van Zyl, LT | 1 |
| Bestehorn, HP; Büttner, HJ; Frundi, D; Hochholzer, W; Neumann, FJ; Stratz, C; Trenk, D; Valina, CM | 1 |
| Fares, RR; Gallati, CA; Lansing, LS; Mousa, SA | 1 |
| Boon, NA; Henriksen, PA; Palmer, K | 1 |
| Makarov, LM; Malinin, AI; Serebrianyĭ, VL | 1 |
| Foley, P | 1 |
| Dorsch, MP; Reaume, KT; Regal, RE | 1 |
| Gladding, P; Olsen, S; Ormiston, J; Webster, M; White, H | 1 |
| Berger, PB; Best, PJ; Brennan, DM; Califf, RM; Dasgupta, A; Steinhubl, SR; Szczech, LA; Topol, EJ | 1 |
| Atiemo, AD; Williams, MS | 1 |
| Gawaz, M; Geisler, T; Paterok, M; Zürn, CS | 1 |
| Ajani, AE; Lefkovits, J | 1 |
| Casterella, PJ; Tcheng, JE | 1 |
| Andraws, R; Pannu, R | 1 |
| Alvarez, W | 1 |
| Tisdale, JE | 1 |
| Collins, M; Colombo, A; Iyer, S; Kreps, E; Maida, R; Moses, JW; Moussa, I; Oetgen, M; Roubin, G; Wang, X | 1 |
| Steinhubl, SR; Topol, EJ | 1 |
| Marks, KR; McCullough, PA | 1 |
| Kaluza, G; Kleiman, NS; Mazur, W | 1 |
| Cummings, CC; Gurbel, PA; O'Connor, CM; Serebruany, VL | 1 |
| Dickinson, JP; Forbes, CD; Kieffer, G; Lowe, GD; MacLaren, M; Shaw, BG | 1 |
| Ferguson, JJ | 1 |
| Willerson, JT; Zoldhelyi, P | 1 |
| Bergman, G; Deutsch, E; Jauhar, R; Parikh, M; Sanborn, TA; Savino, S; Shaknovich, A | 1 |
| Fitzgerald, DJ; Quinn, MJ | 1 |
| Brookes, CI; Sigwart, U | 1 |
| Jafary, FH; Kimmelstiel, CD | 1 |
| Bhatt, DL; Topol, EJ | 1 |
| Asplund, K | 1 |
| Curran, SC; Herrmann, HC; Hirshfeld, JW; Klugherz, BD; Kolansky, DM; Magness, K; Wilensky, RL | 1 |
| Block, PC | 1 |
| Dillon, JC; Dillon, WC; Eckert, GJ; Ritchie, ME | 1 |
| Chinnakotla, S; Fidler, ME; Hammeke, MD; Leone, JP; Tarantolo, S | 1 |
| Steinhubl, SR | 1 |
| Blows, LJ; Calver, AL; Dawkins, KD; Gray, HH; Harmer, S; Morgan, JH; Simpson, IA | 1 |
| Frelinger III, AL; Furman, MI; Michelson, AD | 1 |
| Dieter, RS | 1 |
| Fry, JA; Grines, CL | 1 |
| Bode, C; Nordt, T; Peter, K | 1 |
| Gawaz, M; Müller, I; Pogatsa-Murray, G; Rüdiger, S; Schömig, A; Seyfarth, M; Wolf, B | 2 |
| King, SB | 1 |
| Cannan, CR | 1 |
| Abizaid, AS; Curry, BH; Dangas, G; Kent, KM; Lansky, AJ; Leon, MB; Mehran, R; Paliou, M; Pichard, AD; Satler, LF; Stone, GW | 1 |
| Scheen, AJ | 1 |
| Ajani, AE; Bui, AB; Dieble, R; Gruberg, L; Kent, KK; Lindsay, J; Mintz, GS; Pichard, AD; Pinnow, E; Satler, LF; Taaffe, M; Waksman, R; White, RL | 1 |
| Griffo, R | 1 |
| Davis, CJ; Lowry, DR; McKenzie, ME; Nair, GV; Serebruany, VL | 1 |
| Kilaru, PK; Kozman, HA; Schweiger, MJ; Weil, TR | 1 |
| Calvin, JE; Klein, LW | 1 |
| Gershlick, A; Hogrefe, K; Stephens Lloyd, A; Swanson, N | 1 |
| Kurz, HI; Lasala, JM; Taniuchi, M | 1 |
| Stables, RH | 1 |
| Bertrand, ME; Chrolavicius, S; Copland, I; Fox, KA; Lewis, BS; Malmberg, K; Mehta, SR; Natarajan, MK; Peters, RJ; Rupprecht, H; Yusuf, S; Zhao, F | 1 |
| Anderson, HV; Assali, AR; Fujise, K; Ghani, M; Hale, S; Moustapha, A; Rosales, OR; Salloum, J; Schroth, G; Sdringola, S; Smalling, RW | 1 |
| Callahan, KP; Gurbel, PA; Malinin, AI; Serebruany, VL; Steinhubl, SR | 1 |
| Berger, PB; Bertrand, ME; Bhatt, DL; Dangas, G; Ellis, SG; Holmes, DR; L'Allier, PL; Lasala, JM; Moses, JW; Moussa, I; Taniuchi, M; Topol, EJ | 1 |
| Allen, D | 1 |
| Cannon, C | 1 |
| Dörr, G; Fleck, E; Gräfe, M; Regitz-Zagrosek, V; Schmidt, G | 1 |
| Cianflone, D; Margonato, A; Maseri, A; Pizzetti, G | 1 |
| Maggioni, AP | 1 |
| Taylor, R; Ward, DJ | 1 |
| Berjón Reyero, J | 1 |
| Coxson, PG; Gaspoz, JM; Goldman, L; Goldman, PA; Hunink, MG; Kuntz, KM; Williams, LW | 1 |
| Wood, AJ | 1 |
| Berger, PB; Lubbe, DF | 1 |
| Anderson, HV; Benedict, CR; Buja, LM; Campbell, WB; Cui, K; Maffrand, JP; McNatt, J; Ober, JC; Rosolowsky, M; Yao, SK | 1 |
107 review(s) available for clopidogrel and Coronary Disease
| Article | Year |
|---|---|
Monotherapy with a P2Y
Topics: Aged; Aspirin; Atherosclerosis; Cerebrovascular Disorders; Clopidogrel; Coronary Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Stroke; Ticagrelor; Ticlopidine | 2020 |
The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD).
Topics: Alleles; Asia; Asian People; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Disease Management; Drug Interactions; Drug Resistance; Female; Humans; Male; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Population Surveillance; Purinergic P2Y Receptor Antagonists; Risk Assessment; Risk Factors | 2021 |
[Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Warfarin | 2017 |
Dual antiplatelet therapy after percutaneous coronary intervention for stable CAD or ACS : Redefining the optimal duration of treatment.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemorrhage; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Stents; Ticagrelor | 2018 |
Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel: A meta-analysis.
Topics: Aspirin; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2018 |
High on-clopidogrel platelet reactivity and chronic kidney disease: a meta-analysis of literature studies.
Topics: Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Coronary Disease; Drug Resistance; Female; Humans; Kidney; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Renal Insufficiency, Chronic; Risk Factors; Stents; Treatment Outcome | 2019 |
Antithrombotic dose: Some observations from published clinical trials.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2019 |
[Thrombocyte aggregation inhibitors: what are the risks?].
Topics: Adenosine; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Hemorrhage; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Stents; Thiophenes; Ticagrelor; Ticlopidine | 2013 |
[Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome].
Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Early Medical Intervention; General Practice; Guideline Adherence; Humans; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Secondary Prevention; Stents; Thiophenes; Ticagrelor; Ticlopidine | 2014 |
Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Factor VIIa; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Platelet Transfusion; Recombinant Proteins; Ticlopidine; Treatment Outcome | 2015 |
Perioperative Management to Reduce Cardiovascular Events.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Contraindications; Coronary Disease; Disease Susceptibility; Heparin, Low-Molecular-Weight; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Preanesthetic Medication; Risk Factors; Risk Reduction Behavior; Stress, Physiological; Surgical Procedures, Operative; Thrombophilia; Ticlopidine | 2016 |
[Meta-analysis of the combination of warfarin and clopidogrel after coronary stenting in patients with indications for chronic oral anticoagulation].
Topics: Administration, Oral; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stents; Stroke; Ticlopidine; Warfarin | 2016 |
Does percutaneous coronary stent implantation increase platelet reactivity?
Topics: Blood Platelets; Clopidogrel; Coronary Disease; Humans; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Ticlopidine | 2017 |
Current antiplatelet therapies: benefits and limitations.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2008 |
Clinical implications of aspirin resistance.
Topics: Aspirin; Atherosclerosis; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Drug Resistance; Humans; Ischemia; Research Design; Stroke; Thrombosis; Ticlopidine; Treatment Outcome | 2008 |
Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Biomarkers; C-Reactive Protein; Clopidogrel; Coronary Disease; Female; Humans; Immunoglobulin Fab Fragments; Male; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Preoperative Care; Prognosis; Randomized Controlled Trials as Topic; Ticlopidine | 2009 |
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working
Topics: Aspirin; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine | 2009 |
The present state of aspirin and clopidogrel resistance.
Topics: Anti-Inflammatory Agents; Aspirin; Clopidogrel; Coronary Disease; Drug Monitoring; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2009 |
[Perioperative antiplatelet therapy of patients with coronary stents].
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Disease; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Stents; Thrombosis; Ticlopidine; Time Factors | 2009 |
Platelet monitoring for PCI: is it really necessary?
Topics: Blood Coagulation; Blood Platelets; Clopidogrel; Coronary Disease; Humans; Monitoring, Physiologic; Myocardial Infarction; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Precision Medicine; Ticlopidine | 2009 |
Factors associated with clopidogrel nonresponsiveness.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Coronary Artery Disease; Coronary Disease; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proton Pump Inhibitors; Smoking; Ticlopidine; Treatment Failure | 2010 |
The year in interventional cardiology.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Occlusion; Coronary Restenosis; Drug-Eluting Stents; Foramen Ovale, Patent; Hospital Mortality; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Radiology, Interventional; Thiophenes; Thrombolytic Therapy; Ticagrelor; Ticlopidine; Treatment Outcome | 2010 |
Contemporary management of coronary heart disease.
Topics: Acute Coronary Syndrome; Administration, Oral; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Electrocardiography; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Agonists; Randomized Controlled Trials as Topic; Registries; Secondary Prevention; Ticlopidine; Time Factors; United Kingdom | 2010 |
[Coronary heart disease - what is of importance after coronary intervention?].
Topics: Adenosine; Aftercare; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Drug-Eluting Stents; Gastrointestinal Hemorrhage; Humans; Myocardial Revascularization; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Proton Pump Inhibitors; Stents; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
Clopidogrel-drug interactions.
Topics: Animals; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Polypharmacy; Proton Pump Inhibitors; Ticlopidine | 2011 |
[Comparative antiplatelet efficacy of prasugrel and high-dose clopidogrel in patients with coronary heart disease including acute coronary syndrome].
Topics: Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Thiophenes; Ticlopidine; Time Factors; Treatment Outcome | 2012 |
Clopidogrel and acute coronary syndrome.
Topics: Acute Disease; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine | 2002 |
State of the art--a journey through the world of antithrombotic therapy.
Topics: Ambulatory Care; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Heart Failure; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Orthopedic Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Recurrence; Respiratory Insufficiency; Thromboembolism; Thrombolytic Therapy; Thrombophlebitis; Thrombosis; Ticlopidine | 2002 |
Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes.
Topics: Acute Disease; Algorithms; Clopidogrel; Coronary Disease; Coronary Thrombosis; Enoxaparin; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Risk Factors; Ticlopidine | 2002 |
Clinical implications of CURE and PCI-CURE in patients with the acute coronary syndrome without persistent ST-elevation.
Topics: Acute Disease; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Electrocardiography; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Ticlopidine | 2002 |
Utility of platelet adp receptor antagonism in the emergency department: a review.
Topics: Aspirin; California; Clopidogrel; Coronary Disease; Critical Care; Drug Utilization; Emergency Service, Hospital; Female; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Risk Assessment; Severity of Illness Index; Stroke; Survival Analysis; Ticlopidine; Treatment Outcome | 2003 |
Sirolimus-eluting stents: a review of experimental and clinical findings.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Animals; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Restenosis; Disease Models, Animal; Drug Delivery Systems; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intramuscular; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Rats; Sirolimus; Stents; Swine; Thrombosis; Ticlopidine; Time Factors; Ultrasonography, Interventional | 2002 |
[Platelet inhibitors: old and new].
Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Drug Monitoring; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Thromboxanes; Ticlopidine | 2002 |
Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study.
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Syndrome; Ticlopidine | 2003 |
What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Brachytherapy; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Endothelium, Vascular; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombosis; Ticlopidine; Warfarin | 2003 |
Contemporary use of antiplatelet therapies in percutaneous coronary interventions.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Hirudins; Humans; Immunoglobulin Fab Fragments; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Stents; Ticlopidine | 2003 |
Current management of non-ST-segment-elevation acute coronary syndrome: reconciling the results of randomized controlled trials.
Topics: Anticoagulants; Clopidogrel; Coronary Disease; Echocardiography, Stress; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Syndrome; Ticlopidine | 2003 |
Review of antithrombotic agents used for acute coronary syndromes in renal patients.
Topics: Acute Disease; Anticoagulants; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Hemorrhagic Disorders; Humans; Kidney Diseases; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Ticlopidine | 2003 |
Antiplatelet treatment in stable coronary artery disease.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Drug Interactions; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Ticlopidine | 2003 |
The role of clopidogrel in the management of acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Drug Interactions; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2003 |
Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.
Topics: Adult; Aged; Clopidogrel; Combined Modality Therapy; Confidence Intervals; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Odds Ratio; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Stents; Survival Analysis; Ticlopidine; Treatment Outcome; Vascular Patency | 2003 |
[Role of glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes].
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2003 |
Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2004 |
[Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].
Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Stroke; Ticlopidine | 2004 |
Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis.
Topics: Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Ticlopidine | 2004 |
[Acute coronary syndromes without ST segment elevation].
Topics: Acute Disease; Adrenergic beta-Antagonists; Analgesics, Opioid; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Calcium Channel Blockers; Clopidogrel; Coronary Disease; Electrocardiography; Enoxaparin; Humans; Morphine; Myocardial Revascularization; Oxygen Inhalation Therapy; Patient Selection; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Ticlopidine; Time Factors | 2004 |
Role of clopidogrel in unstable angina and non-ST-segment elevation myocardial infarction: from literature and guidelines to practice.
Topics: Angina, Unstable; Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Hemorrhage; Humans; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine | 2004 |
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Aspirin; Clopidogrel; Contraindications; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Internal Mammary-Coronary Artery Anastomosis; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Assessment; Ticlopidine; Veins | 2004 |
Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Drug Therapy, Combination; Electrocardiography; Humans; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 2004 |
Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
Topics: Administration, Oral; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Drug Synergism; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2004 |
[Antithrombotic therapy of acute coronary syndromes].
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Thrombolytic Therapy; Ticlopidine | 2005 |
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Administration Schedule; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2005 |
Clopidogrel in acute coronary syndrome: when, how much, how long?
Topics: Acute Disease; Angina, Unstable; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Germany; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Syndrome; Ticlopidine; Treatment Outcome | 2005 |
Resistance to antiplatelet therapy.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Drug Tolerance; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine | 2005 |
CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction.
Topics: Acute Disease; Clopidogrel; Coronary Disease; Humans; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Syndrome; Ticlopidine | 2005 |
Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.
Topics: Acute Disease; Clopidogrel; Coronary Disease; Electrocardiography; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine | 2005 |
Clopidogrel in acute coronary heart disease.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents; Ticlopidine | 2005 |
[PCI: state of the art].
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Coronary Restenosis; Humans; Japan; Platelet Aggregation Inhibitors; Prognosis; Stents; Thrombosis; Ticlopidine | 2006 |
Is clopidogrel cardiovascular medicine's double-edged sword?
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 2006 |
Percutaneous coronary intervention in a patient with von Willebrand's disease presenting with an acute coronary syndrome.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticoagulants; Clopidogrel; Coronary Angiography; Coronary Disease; Epistaxis; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Syndrome; Ticlopidine; von Willebrand Diseases | 2006 |
Clopidogrel: a pharmacoeconomic review of its use in patients with non-ST elevation acute coronary syndromes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Markov Chains; Platelet Aggregation Inhibitors; Prescription Fees; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Ticlopidine | 2006 |
Clopidogrel treatment surrounding percutaneous coronary intervention: when should it be started and stopped?
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2006 |
Debate of adjunctive pharmacology for percutaneous coronary intervention: thrombin inhibitors and clopidogrel are enough.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Clopidogrel; Combined Modality Therapy; Coronary Disease; Heparin; Hirudins; Humans; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recombinant Proteins; Ticlopidine | 2006 |
The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
Clinical applications of antiplatelet therapy.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Drug Resistance; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Pyridines; Ticlopidine | 2006 |
Prasugrel.
Topics: Adenosine Diphosphate; Animals; Aspirin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Clopidogrel; Collagen; Coronary Disease; Drug Evaluation, Preclinical; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prodrugs; Purinergic P2 Receptor Antagonists; Pyridines; Rats; Receptors, Purinergic P2Y12; Thiophenes; Ticlopidine | 2006 |
[Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients].
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Coronary Thrombosis; Diabetes Complications; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Renal Insufficiency; Risk Factors; Syndrome; Ticlopidine; Tirofiban; Troponin; Tyrosine | 2006 |
Platelet P2 receptors: old and new targets for antithrombotic drugs.
Topics: Adenosine; Adenosine Monophosphate; Angina, Unstable; Animals; Blood Platelets; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Interactions; Fibrinolytic Agents; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2X; Syndrome; Thiophenes; Ticagrelor; Ticlopidine | 2007 |
Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Therapy, Combination; Guideline Adherence; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Registries; Research Design; Risk Factors; Syndrome; Ticlopidine | 2006 |
Oral antiplatelet therapy for percutaneous coronary revascularization.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Ticlopidine | 2007 |
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
Topics: Aspirin; Atherosclerosis; Cilostazol; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Dipyridamole; Disease Susceptibility; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Hemorrhage; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vasodilator Agents | 2007 |
Use of clopidogrel in coronary artery disease.
Topics: Clopidogrel; Coronary Disease; Electrocardiography; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2007 |
Clopidogrel resistance--the cardiologist's perspective.
Topics: Blood Platelets; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2007 |
Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome; Ticlopidine; Warfarin | 2007 |
[Cardiology 2007].
Topics: Angioplasty, Balloon, Coronary; Cardiopulmonary Resuscitation; Cholesterol; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Heart Failure; Heart Massage; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2007 |
The role of clopidogrel in revascularized and nonrevascularized patients with acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Cost-Benefit Analysis; Guideline Adherence; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Ticlopidine | 2007 |
Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Humans; Membrane Proteins; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine | 2007 |
Platelet function monitoring in patients with coronary artery disease.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Disease; Drug Resistance; Humans; Monitoring, Physiologic; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Ticlopidine; Treatment Outcome | 2007 |
ADP receptor antagonism: what's in the pipeline?
Topics: Adenosine; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronary Disease; Humans; Membrane Proteins; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine | 2007 |
Antiplatelet therapy with clopidogrel and aspirin in vascular diseases: clinical evidence for and against the combination.
Topics: Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine | 2008 |
[Clopidogrel resistance: myth or reality].
Topics: Clopidogrel; Coronary Disease; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Ticlopidine | 2007 |
Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Brain Ischemia; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Drug-Eluting Stents; Evidence-Based Medicine; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2008 |
Antiplatelet drug nonresponsiveness.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Coronary Disease; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine | 2008 |
Clopidogrel use in coronary heart disease and percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Drug Interactions; Drug Resistance; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine | 2008 |
Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: practical implications, new clinical da
Topics: American Heart Association; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Disease; Drug-Eluting Stents; Hirudins; Humans; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Pyridines; Recombinant Proteins; Societies, Medical; Thrombolytic Therapy; Ticlopidine; United States | 2008 |
Effects of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel: a meta-analysis of randomized trials.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Confidence Intervals; Coronary Angiography; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunoglobulin Fab Fragments; Male; Odds Ratio; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Ticlopidine; Treatment Outcome | 2008 |
Antiplatelet therapy in coronary artery disease: review and update of efficacy studies.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Ticlopidine | 1998 |
Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Hematologic Diseases; Humans; Platelet Aggregation Inhibitors; Premedication; Randomized Controlled Trials as Topic; Stents; Ticlopidine | 1999 |
Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.
Topics: Anemia, Aplastic; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Health Policy; Hematologic Diseases; Hemorrhage; Humans; Multivariate Analysis; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Premedication; Purpura, Thrombotic Thrombocytopenic; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Stents; Ticlopidine; Treatment Outcome | 1999 |
Antiplatelet therapy for treatment of acute coronary syndromes.
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Vascular Patency | 1999 |
Clopidogrel: the future choice for preventing platelet activation during coronary stenting?
Topics: Clopidogrel; Coronary Disease; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 1999 |
Future directions in thrombolysis.
Topics: Clopidogrel; Coronary Disease; Coronary Thrombosis; Cyclooxygenase 2; Enzyme Inhibitors; Fibrinolytic Agents; Forecasting; Humans; Isoenzymes; Membrane Proteins; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prostaglandin-Endoperoxide Synthases; Thrombolytic Therapy; Ticlopidine | 1999 |
Ticlopidine and clopidogrel.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bone Marrow Diseases; Carbamazepine; Cardiovascular Diseases; Clopidogrel; Combined Modality Therapy; Coronary Disease; Drug Interactions; Hemorrhage; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Phenytoin; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Safety; Stents; Theophylline; Thrombolytic Therapy; Ticlopidine | 1999 |
Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Drug Administration Schedule; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Stents; Thrombosis; Ticlopidine | 2000 |
Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease.
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine; Treatment Outcome | 2000 |
Antiplatelet agents in cardiology: the choice of therapy.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine | 2000 |
The thienopyridines in coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Ticlopidine | 1999 |
Antithrombotic therapy in the cardiac catheterization laboratory: focus on antiplatelet agents.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiac Catheterization; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine | 2000 |
Optimization of platelet therapy.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Atherectomy, Coronary; Clopidogrel; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents; Ticlopidine; Treatment Outcome | 2000 |
[Therapeutic inhibition of platelets in a acute coronary syndrome and in coronary intervention: mechanisms and clinical results].
Topics: Abciximab; Acute Disease; Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Aspirin; Blood Platelets; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Humans; Immunoglobulin Fab Fragments; Meta-Analysis as Topic; Mice; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Stents; Syndrome; Ticlopidine | 2000 |
Optimizing antiplatelet therapy in coronary interventions.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents; Ticlopidine | 2000 |
Antithrombotic therapy in cardiac stent patients.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine | 2001 |
Aspirin in patients with coronary artery disease: is it simply irresistible?
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Benzamidines; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Diabetes Complications; Dipyridamole; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Endothelium, Vascular; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Oximes; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Thrombosis; Thromboxane-A Synthase; Ticlopidine; Vasodilator Agents | 2001 |
The use of antiplatelet agents in acute cardiac care.
Topics: Aspirin; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2001 |
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting.
Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Registries; Stents; Ticlopidine | 2002 |
[Role of clopidogrel in acute coronary syndromes without ST-segment elevation].
Topics: Acute Disease; Administration, Oral; Clopidogrel; Coronary Disease; Electrocardiography; Humans; Infusions, Parenteral; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine | 2002 |
The thienopyridines.
Topics: Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Pyridines; Ticlopidine | 2002 |
93 trial(s) available for clopidogrel and Coronary Disease
| Article | Year |
|---|---|
Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study.
Topics: Aged; Clopidogrel; Coronary Angiography; Coronary Disease; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine | 2020 |
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents.
Topics: Aged; Aspirin; Clinical Decision-Making; Clopidogrel; Coronary Disease; Coronary Thrombosis; Decision Support Techniques; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Reproducibility of Results; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
PIK3CG single nucleotide polymorphisms are associated with poor responsiveness to clopidogrel and increased risk of ischemia in patients with coronary heart disease.
Topics: Aged; Class Ib Phosphatidylinositol 3-Kinase; Clopidogrel; Coronary Disease; Drug Resistance; Female; Gene Frequency; Haplotypes; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Ticlopidine | 2017 |
Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting.
Topics: Aged; Aspirin; Clopidogrel; Comorbidity; Coronary Artery Bypass; Coronary Disease; Costs and Cost Analysis; Drug Therapy, Combination; Female; Hospitals, Veterans; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Treatment Outcome | 2018 |
Interaction of clopidogrel and fufang danshen dripping pills assay in coronary heart disease based on non-target metabolomics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Camphanes; Case-Control Studies; Chromatography, Liquid; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Gas Chromatography-Mass Spectrometry; Herb-Drug Interactions; Humans; Lipid Metabolism; Mass Spectrometry; Metabolomics; Middle Aged; Panax notoginseng; Platelet Aggregation Inhibitors; Salvia miltiorrhiza; Young Adult | 2019 |
Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity.
Topics: Aged; Blood Platelets; Clopidogrel; Coronary Disease; Down-Regulation; Female; Humans; Male; MicroRNAs; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine | 2013 |
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
Topics: Aspirin; Blood Coagulation Tests; Clopidogrel; Coronary Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Point-of-Care Systems; Prospective Studies; Registries; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
[Effect of aspirin plus clopidogrel therapy on aspirin resistance after off-pump coronary artery bypass surgery].
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Period; Ticlopidine | 2013 |
Effect of clopidogrel use post coronary artery bypass surgery on graft patency.
Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Education, Medical, Continuing; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Postoperative Care; Prospective Studies; Reference Values; Regression Analysis; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency | 2014 |
Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy.
Topics: Aged; Anticholesteremic Agents; Aspirin; Azetidines; Cell-Derived Microparticles; Cholesterol, LDL; Clopidogrel; Coronary Disease; Drug Combinations; Endothelial Progenitor Cells; Ezetimibe; Female; Flow Cytometry; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Simvastatin; Ticlopidine; Triglycerides | 2014 |
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.
Topics: Aged; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP2C19; Double-Blind Method; Elective Surgical Procedures; Female; Follow-Up Studies; Gene Frequency; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Stents; Thiophenes; Ticlopidine | 2014 |
Does smoking habit affect the randomized comparison of 6 versus 24-month dual antiplatelet therapy duration? Insights from the PRODIGY trial.
Topics: Aged; Clopidogrel; Coronary Disease; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Smoking; Stents; Ticlopidine; Time Factors | 2015 |
[The possibility of selecting optimal antiplatelet therapy in patients with coronary heart disease in terms of CYP2C19 polymorphism].
Topics: Aspirin; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Ticlopidine | 2016 |
Randomized Comparison of Oral P2Y
Topics: Adenosine; Adenosine Monophosphate; Administration, Oral; Aged; Blood Platelets; Clopidogrel; Coronary Disease; Drug Substitution; Female; Germany; Humans; Infusions, Intravenous; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Optimal Same-Day Platelet Inhibition in Patients Receiving Drug-Eluting Stents With or Without Previous Maintenance Thienopyridine Therapy: from the Evaluation of Platelet Inhibition in Patients Having A VerifyNow Assay (EPIPHANY) Trial.
Topics: Clopidogrel; Coronary Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Pyridines; Risk Factors; Ticlopidine; Treatment Outcome | 2017 |
Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets.
Topics: Adrenergic beta-Antagonists; Adult; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nitric Oxide; Platelet Aggregation Inhibitors; Receptors, Adrenergic, beta; Signal Transduction; Ticlopidine | 2008 |
Effect of PCI on quality of life in patients with stable coronary disease.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Calcium Channel Blockers; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cross-Over Studies; Drug Therapy, Combination; Female; Health Status; Humans; Isosorbide Dinitrate; Male; Metoprolol; Middle Aged; Patient Satisfaction; Platelet Aggregation Inhibitors; Quality of Life; Stents; Surveys and Questionnaires; Ticlopidine; Vasodilator Agents | 2008 |
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease.
Topics: Aged; Aspirin; Body Mass Index; Clopidogrel; Coronary Disease; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Thrombosis; Ticlopidine | 2009 |
Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients W
Topics: Cilostazol; Clopidogrel; Coronary Disease; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Ticlopidine | 2009 |
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease.
Topics: Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Drug Interactions; Female; Genetic Variation; Humans; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine | 2009 |
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study.
Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Coronary Disease; Cross-Over Studies; Female; Fibrinogen; Flow Cytometry; Health; Humans; Male; Middle Aged; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Principal Component Analysis; Regression Analysis; Thromboxane B2; Ticlopidine | 2009 |
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Topics: Adenosine Diphosphate; Aged; Aspirin; Atorvastatin; Clopidogrel; Comorbidity; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Prospective Studies; Pyrroles; Ticlopidine | 2010 |
Duration of dual antiplatelet therapy after implantation of drug-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retreatment; Stroke; Thrombosis; Ticlopidine | 2010 |
Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study.
Topics: Adenosine; Aged; Aspirin; Clopidogrel; Coronary Disease; Double-Blind Method; Dyspnea; Female; Heart; Humans; Lung; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Ticagrelor; Ticlopidine | 2010 |
[Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Angioplasty, Balloon; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Aggregation; Postoperative Period; Proton Pump Inhibitors; Stents; Ticlopidine | 2010 |
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Coronary Restenosis; Coronary Vessels; Dose-Response Relationship, Drug; Drug-Eluting Stents; Follow-Up Studies; Humans; Hyperplasia; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors; Treatment Outcome; Tunica Intima | 2010 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
Comparison of antiplatelet effect and tolerability of clopidogrel resinate with clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD-equivalent risks: a phase IV, prospective, double-dummy, parallel-group, 4-week noninferiority trial
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Point-of-Care Systems; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine | 2011 |
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.
Topics: Aged; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Disease; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Treatment Outcome | 2012 |
[Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coronary Disease; Double-Blind Method; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Prospective Studies; Ticlopidine; Tissue Plasminogen Activator; von Willebrand Factor | 2012 |
Impact of clopidogrel and aspirin treatment on the expression of proteins in platelets from type-2 diabetic patients with stable coronary ischemia.
Topics: Aged; Amino Acid Sequence; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Cytoskeletal Proteins; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gene Expression Regulation; Humans; Male; Molecular Sequence Data; Platelet Aggregation Inhibitors; Platelet Factor 4; Proteome; Ticlopidine | 2012 |
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial.
Topics: Adult; Aged; Aspirin; Blood Loss, Surgical; Blood Platelets; Clopidogrel; Confounding Factors, Epidemiologic; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Thiophenes; Ticlopidine | 2012 |
Bedside monitoring to adjust antiplatelet therapy for coronary stenting.
Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Monitoring; Female; Humans; Male; Middle Aged; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Point-of-Care Systems; Prasugrel Hydrochloride; Pyridines; Retreatment; Stents; Thiophenes; Ticlopidine | 2012 |
Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial).
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Elective Surgical Procedures; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Stents; Ticlopidine; Tirofiban; Troponin T; Tyrosine | 2002 |
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups.
Topics: Acute Disease; Aged; Aspirin; Clopidogrel; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Ticlopidine; Treatment Outcome | 2002 |
Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes.
Topics: Antigens; Aspirin; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Clopidogrel; Cohort Studies; Coronary Disease; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; P-Selectin; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome; von Willebrand Factor | 2002 |
Comparison of clopidogrel versus ticlopidine for prevention of minor myocardial injury after elective coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Reperfusion Injury; Primary Prevention; Probability; Prospective Studies; Risk Assessment; Stents; Ticlopidine; Treatment Outcome | 2003 |
Coronary stenting in stable patients: identification of a low-risk subgroup that may not require adjunctive antiplatelet therapy.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Chemotherapy, Adjuvant; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Male; Probability; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Stents; Survival Analysis; Ticlopidine; Treatment Outcome | 2003 |
The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: to what extent should the results be generalizable?
Topics: Angina, Unstable; Aspirin; Clopidogrel; Coronary Disease; Double-Blind Method; Female; Heart Failure; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Stents; Stroke; Thrombosis; Ticlopidine | 2003 |
A paclitaxel-eluting stent for the prevention of coronary restenosis.
Topics: Angiogenesis Inhibitors; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Restenosis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Tunica Intima; Ultrasonography, Interventional | 2003 |
Durability of platelet inhibition by clopidogrel.
Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors | 2003 |
[Non ST elevation acute coronary syndrome. Parameters of fibrinolysis during short term use of ticlopidine or clopidogrel].
Topics: Acute Disease; Adult; Antithrombins; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Fibrinolysis; Humans; Male; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine; Time Factors | 2003 |
[Clopidogrel as adjunctive medication in patients with acute coronary syndrome].
Topics: Aspirin; Clopidogrel; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Placebo Effect; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2002 |
A comparison of 1-month and 6-month clopidogrel therapy on clinical and angiographic outcome after stent implantation.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug Administration Schedule; Female; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2003 |
Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function--a flow cytometry study.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Flow Cytometry; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; P-Selectin; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Ticlopidine; Time Factors | 2003 |
Effects of 2 different antiplatelet regimens with abciximab or tirofiban on platelet function in patients undergoing coronary stenting.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stents; Ticlopidine; Tirofiban; Tyrosine | 2003 |
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Therapy, Combination; Female; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Preoperative Care; Ticlopidine | 2004 |
Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery.
Topics: Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Female; Humans; Length of Stay; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Prospective Studies; Risk Factors; Ticlopidine | 2004 |
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; CD40 Ligand; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inactivation, Metabolic; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Stents; Ticlopidine; Treatment Outcome | 2004 |
Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the CURE trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Clopidogrel; Coronary Disease; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Epidemiologic Methods; Female; Health Care Costs; Humans; Male; Markov Chains; Middle Aged; Models, Econometric; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Sweden; Ticlopidine | 2004 |
Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Angiography; Coronary Disease; Creatine Kinase; Creatine Kinase, MB Form; Female; Follow-Up Studies; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Netherlands; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Treatment Outcome; Troponin I | 2004 |
Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy.
Topics: Aged; Aspirin; Blood Platelets; C-Reactive Protein; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Ticlopidine | 2004 |
Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Clopidogrel; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Hirudins; Humans; Male; Middle Aged; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Survival Analysis; Ticlopidine; Treatment Outcome | 2004 |
[Dysaggregants effect of platelet aggregation in patients with non-ST segment elevation acute coronary syndrome].
Topics: Acute Disease; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Electrocardiography; Female; Humans; Male; Nadroparin; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine | 2004 |
Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents; Ticlopidine; Treatment Outcome | 2004 |
Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Creatine Kinase; Creatine Kinase, MB Form; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Isoenzymes; Logistic Models; Male; Middle Aged; Neovascularization, Pathologic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Recurrence; Stents; Survival Rate; Thrombosis; Ticlopidine; Troponin T | 2005 |
GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Topics: Abciximab; Acute Disease; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Platelets; CD40 Ligand; Clopidogrel; Coronary Disease; Female; Humans; Immunoglobulin Fab Fragments; Inflammation; Leukocytes; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2005 |
Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation.
Topics: Acute Disease; Aged; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Electrocardiography; Female; Follow-Up Studies; Humans; Length of Stay; Life Expectancy; Male; Medicare; Middle Aged; Myocardial Infarction; Patient Admission; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Sensitivity and Specificity; Syndrome; Ticlopidine; Time; Treatment Outcome; United States | 2005 |
The effect of tirofiban and clopidogrel pretreatment on outcome of old saphenous vein graft stenting in patients with acute coronary syndromes.
Topics: Acute Disease; Clopidogrel; Coronary Disease; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Saphenous Vein; Stents; Ticlopidine; Tirofiban; Tyrosine | 2005 |
Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the PREVENT Trial [corrected].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biocompatible Materials; Carbon; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Coronary Restenosis; Equipment Design; Female; Heparin; Humans; Male; Materials Testing; Middle Aged; Prospective Studies; Recurrence; Stainless Steel; Stents; Thromboembolism; Thrombophilia; Ticlopidine; Time Factors; Treatment Outcome; Venous Thrombosis | 2005 |
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Female; Humans; Ischemia; Leg; Male; Middle Aged; Myocardial Infarction; Risk Factors; Ticlopidine | 2005 |
A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Blood Coagulation; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Restenosis; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stents; Ticlopidine | 2005 |
Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.
Topics: Adult; Alleles; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Disease; Epinephrine; Female; Humans; Integrin alpha2; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Ticlopidine | 2005 |
Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect)
Topics: Administration, Oral; Aged; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Intestinal Absorption; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Stents; Ticlopidine | 2005 |
Aspirin, warfarin and a thienopyridine for acute coronary syndromes.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Hematologic Agents; Humans; Male; Pyridines; Risk Factors; Syndrome; Ticlopidine; Ventricular Function; Warfarin | 2006 |
Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Recurrence; Survival Analysis; Ticlopidine; Treatment Outcome | 2005 |
High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Premedication; Prospective Studies; Risk Factors; Secondary Prevention; Stents; Syndrome; Ticlopidine; Treatment Outcome | 2006 |
A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent.
Topics: Adult; Aged; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Ticlopidine | 2006 |
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Topics: Adenosine Diphosphate; Adult; Aged; Alprostadil; Blood Platelets; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Stents; Thrombosis; Ticlopidine | 2007 |
Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study.
Topics: Clopidogrel; Coronary Disease; Female; Flow Cytometry; Humans; Male; Middle Aged; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Stents; Thiophenes; Ticlopidine | 2006 |
[Short-term outcomes of triple antiplatelet therapy after percutaneous coronary intervention].
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Period; Retrospective Studies; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2006 |
Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.
Topics: Adult; Aged; Clopidogrel; Coronary Disease; Desensitization, Immunologic; Dose-Response Relationship, Drug; Drug Hypersensitivity; Exanthema; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Time Factors | 2006 |
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infar
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Research Design; Syndrome; Thiophenes; Thrombolytic Therapy; Thrombosis; Ticlopidine; Treatment Outcome | 2006 |
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease.
Topics: Aspirin; Biomarkers; Chemokine CCL2; Clopidogrel; Coronary Disease; Humans; Inflammation; Ticlopidine; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Normalization of platelet reactivity in clopidogrel-treated subjects.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Collagen; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Platelet-Rich Plasma; Postoperative Hemorrhage; Receptors, Thrombin; Recovery of Function; Reference Values; Ticlopidine; Time Factors | 2007 |
Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
Topics: Aspirin; Carbon; Cause of Death; Clopidogrel; Coated Materials, Biocompatible; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Combinations; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prospective Studies; Reoperation; Stents; Ticlopidine; Treatment Outcome | 2007 |
Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
Topics: Aged; Angina, Unstable; Clopidogrel; Coronary Disease; Creatinine; Double-Blind Method; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Research Design; Risk Factors; Severity of Illness Index; Survival Analysis; Syndrome; Ticlopidine; Treatment Outcome | 2007 |
Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study.
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Vessels; Drug Therapy, Combination; Female; Humans; Hyperplasia; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tetrazoles; Ticlopidine; Tunica Intima; Ultrasonography, Interventional | 2007 |
Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
Topics: Adult; Aged; Antidepressive Agents; Aspirin; beta-Thromboglobulin; Biomarkers; Blood Platelets; Citalopram; Clopidogrel; Comorbidity; Coronary Disease; Depressive Disorder, Major; Drug Interactions; Endothelium, Vascular; Female; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Nitric Oxide; P-Selectin; Platelet Aggregation Inhibitors; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Ticlopidine; Young Adult | 2009 |
Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Coronary Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Female; Flow Cytometry; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Pyrroles; Simvastatin; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2008 |
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Renal Insufficiency, Chronic; Stents; Ticlopidine; Treatment Outcome | 2008 |
Approaching an age of reason with antiplatelet therapy.
Topics: Clopidogrel; Coronary Disease; Humans; Membrane Proteins; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Thiophenes; Thrombosis; Ticlopidine | 2008 |
Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Diarrhea; Drug Eruptions; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Neutropenia; Platelet Aggregation Inhibitors; Postoperative Complications; Safety; Stents; Ticlopidine; Treatment Outcome | 1999 |
Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist.
Topics: Adrenergic beta-Antagonists; Adult; Arterial Occlusive Diseases; Atenolol; Calcium Channel Blockers; Clopidogrel; Coronary Disease; Cross-Over Studies; Double-Blind Method; Drug Incompatibility; Female; Humans; Male; Middle Aged; Nifedipine; Platelet Aggregation Inhibitors; Ticlopidine | 1999 |
[Acute coronary syndrome, stent and cardiac insufficiency. Advances in thrombosis prevention].
Topics: Acute Disease; Clopidogrel; Coronary Disease; Coronary Thrombosis; Coumarins; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 1999 |
Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement.
Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Humans; Platelet Activation; Platelet Aggregation; Stents; Ticlopidine | 2001 |
Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Recurrence; Stents; Ticlopidine | 2001 |
Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS).
Topics: Aged; Clopidogrel; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Gamma Rays; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2001 |
Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population.
Topics: Abciximab; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Coronary Thrombosis; Eptifibatide; Exanthema; Female; Gastrointestinal Diseases; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Neutropenia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Ticlopidine; Tirofiban; Tyrosine | 2001 |
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Preoperative Care; Proportional Hazards Models; Prospective Studies; Risk; Survival Analysis; Ticlopidine; Treatment Outcome | 2001 |
Clopidogrel: a CURE in acute coronary syndromes?
Topics: Acute Disease; Aged; Aspirin; Clopidogrel; Coronary Disease; Double-Blind Method; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome | 2002 |
Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation.
Topics: Adenosine Diphosphate; Aged; Aspirin; Clopidogrel; Coronary Disease; Drug Synergism; Drug Therapy, Combination; Dual Specificity Phosphatase 2; Female; Humans; Male; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Ticlopidine | 2002 |
Clopidogrel and the CURE results.
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2001 |
244 other study(ies) available for clopidogrel and Coronary Disease
| Article | Year |
|---|---|
Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Treatment Outcome | 2022 |
Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China.
Topics: Aged; Aspirin; Cerebral Infarction; China; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Genotype; Humans; Ischemic Stroke; Middle Aged; Polymorphism, Genetic; Ticlopidine | 2022 |
Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease.
Topics: Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Genotype; Humans; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12 | 2022 |
Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole.
Topics: Adult; Anti-Ulcer Agents; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Treatment Outcome; Young Adult | 2020 |
A SNP involved in alternative splicing of
Topics: Aged; Alternative Splicing; Asian People; ATP Binding Cassette Transporter, Subfamily B; Clopidogrel; Coronary Disease; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide | 2020 |
Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events.
Topics: Clopidogrel; Cohort Studies; Coronary Disease; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome | 2022 |
Relationship between thromboelastography and long-term ischemic events as gauged by the response to clopidogrel in patients undergoing elective percutaneous coronary intervention.
Topics: Clopidogrel; Coronary Disease; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ROC Curve; Thrombelastography; Ticlopidine | 2017 |
Recommendations on the Clinical Use of Compound Danshen Dripping Pills.
Topics: Angina Pectoris; Aspirin; Camphanes; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Drugs, Chinese Herbal; Humans; Meta-Analysis as Topic; Panax notoginseng; Salvia miltiorrhiza; Ticlopidine | 2017 |
Effect of Dialysis on Antiplatelet Drug Efficacy in Uremic Patients with Coronary Heart Disease.
Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Renal Dialysis; Thrombelastography; Ticlopidine; Uremia | 2017 |
Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI).
Topics: Adenosine; Aged; Blood Platelets; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Mutation; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine | 2017 |
Safety and Necessity of Antiplatelet Therapy on Patients Underwent Endovascular Aortic Repair with Both Stanford Type B Aortic Dissection and Coronary Heart Disease.
Topics: Adult; Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine | 2017 |
CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment.
Topics: Aged; Analysis of Variance; ATP Binding Cassette Transporter, Subfamily B; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; DNA Mutational Analysis; Female; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Recurrence; Retrospective Studies; Ticlopidine | 2018 |
Clinical Outcomes and Sustainability of Using
Topics: Aged; Clinical Decision-Making; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Feasibility Studies; Female; Humans; Male; Middle Aged; North Carolina; Patient Selection; Percutaneous Coronary Intervention; Pharmacogenomic Testing; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Risk Factors; Stents; Ticagrelor; Treatment Outcome | 2018 |
Influence of drugs on the prospective diagnostic method for coronary heart disease with urine.
Topics: Aspirin; Becaplermin; Clopidogrel; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Spectrum Analysis, Raman | 2019 |
Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease.
Topics: Acute Coronary Syndrome; Aftercare; Clopidogrel; Comorbidity; Coronary Disease; Drug Utilization; Female; Follow-Up Studies; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Metabolic Syndrome; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proportional Hazards Models; Prospective Studies; Smoking; Spain; Stroke; Tertiary Care Centers; Ticagrelor | 2019 |
Variability of platelet responses to adenosine diphosphate.
Topics: Blood Platelets; Clopidogrel; Coronary Disease; Down-Regulation; Female; Humans; Male; MicroRNAs; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2013 |
Anti-thrombotic treatment in patients with a long-term indication for anticoagulant therapy undergoing coronary stenting.
Topics: Anticoagulants; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2013 |
Ask the doctors. I recently had a drug-eluting stent placed in one of my coronary arteries after an episode of severe chest pain. My doctor told me I had to take Plavix every day. Now I feel perfectly fine-except for my right hip. I need a hip replace
Topics: Anticoagulants; Clopidogrel; Coronary Disease; Health Behavior; Hip Fractures; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Stents; Ticlopidine; Withholding Treatment | 2013 |
Acquired pure red cell aplasia due to treatment with clopidogrel: first case report.
Topics: Clopidogrel; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Hypertension; Middle Aged; Platelet Aggregation Inhibitors; Red-Cell Aplasia, Pure; Ticlopidine | 2014 |
Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspirin; China; Clopidogrel; Computer Simulation; Coronary Disease; Cost-Benefit Analysis; Electrocardiography; Heparin; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Markov Chains; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Ticlopidine | 2014 |
[Resistance to clopidogrel and polymorphism of P2RY12 and GPIIIA genes in patients with chronic coronary heart disease].
Topics: Alleles; Chronic Disease; Clopidogrel; Coronary Disease; DNA; Drug Resistance; Female; Genotype; Humans; Integrin beta3; Male; Middle Aged; Polymorphism, Genetic; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine | 2013 |
[Real-world study in analysis of effects on concomitant medications with parenterally administered shenmai for coronary heart disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Disease; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hospital Information Systems; Humans; Infusions, Parenteral; Logistic Models; Male; Middle Aged; Outcome Assessment, Health Care; Pragmatic Clinical Trials as Topic; Ticlopidine; Treatment Outcome; Young Adult | 2013 |
[Analysis of salvianolate injection combined with usual drugs in treatment of coronary heart disease in real world].
Topics: Aged; Aged, 80 and over; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hospital Information Systems; Humans; Isosorbide Dinitrate; Male; Middle Aged; Plant Extracts; Pragmatic Clinical Trials as Topic; Propensity Score; Ticlopidine; Treatment Outcome | 2013 |
Positive clinical response to clopidogrel is independent of paraoxonase 1 Q192R and CYP2C19 genetic variants.
Topics: Aged; Alleles; Angina Pectoris; Aryldialkylphosphatase; Aspirin; Clopidogrel; Cohort Studies; Coronary Disease; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Drug Therapy, Combination; Female; Genetic Variation; Genotype; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Recurrence; Risk Factors; Ticlopidine; Treatment Outcome | 2014 |
The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease.
Topics: Aged; Aryldialkylphosphatase; Aspirin; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Carboxylic Ester Hydrolases; Case-Control Studies; China; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Female; Genetic Variation; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Stents; Ticlopidine | 2014 |
CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention.
Topics: Aged; Biomarkers; Blood Platelets; Body Mass Index; Cell Adhesion Molecules; China; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Diabetes Mellitus, Type 2; Drug Resistance; Female; Gene Frequency; Genotype; Humans; Male; Microfilament Proteins; Middle Aged; Oligonucleotide Array Sequence Analysis; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Phosphoproteins; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Risk Factors; Ticlopidine; Treatment Outcome | 2014 |
Factors determining the total serum antioxidant capacity in men with coronary heart disease--the powerful effect of treatment with thienopyridines.
Topics: Adult; Aged; Antioxidants; Biomarkers; Cardiotonic Agents; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Male; Middle Aged; Oxidative Stress; Thienopyridines; Ticlopidine; Uric Acid | 2014 |
Bleeding complication with dual antiplatelet therapy: spontaneous uvula hematoma.
Topics: Aged, 80 and over; Aspirin; Clopidogrel; Coronary Disease; Drug Interactions; Hematoma; Humans; Laryngoscopy; Male; Metoprolol; Platelet Aggregation Inhibitors; Ticlopidine; Uvula | 2014 |
Evaluation of resistance to anti-platelet therapy in patients with coronary heart disease in a developing country.
Topics: Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Developing Countries; Drug Resistance; Hospitals, University; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Saudi Arabia; Ticlopidine; Time Factors; Treatment Outcome | 2014 |
[Analysis of traditional Chinese medicine syndrome, traditional Chinese medicine and western medicine in 84 697 patients with coronary heart disease based on big data].
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Disease; Drugs, Chinese Herbal; Female; Humans; Isosorbide Dinitrate; Male; Medicine, Chinese Traditional; Middle Aged; Ticlopidine | 2014 |
[Paroxysmal atrial fibrillation well controlled. Why the sudden patient syncope?].
Topics: Amiodarone; Atrial Fibrillation; Clopidogrel; Coronary Disease; Diagnosis, Differential; Drug Therapy, Combination; Electrocardiography; Humans; Long QT Syndrome; Male; Middle Aged; Risk Factors; Syncope; Ticlopidine; Torsades de Pointes | 2015 |
Angiographic and clinical results of everolimus-eluting stent utilization in saphenous vein graft lesions (ARES).
Topics: Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Drug-Eluting Stents; Everolimus; Female; Graft Occlusion, Vascular; Humans; Male; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Reoperation; Saphenous Vein; Ticlopidine | 2015 |
Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy.
Topics: Aged; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Esomeprazole; Ethnicity; Female; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome | 2015 |
[Positive effect of low-activity thromboxane A synthase gene on prognosis in coronary heart disease].
Topics: Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Data Interpretation, Statistical; Drug Resistance; Female; Gene Frequency; Humans; Kaplan-Meier Estimate; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prognosis; Prospective Studies; Risk; Thromboxane-A Synthase; Ticlopidine | 2015 |
[The ISAR-SAFE study].
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Administration Schedule; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Research Design; Risk; Thrombosis; Ticlopidine | 2015 |
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
Topics: Activation, Metabolic; Aged; Aspirin; Brachial Artery; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Drug Synergism; Drug Therapy, Combination; Endothelium, Vascular; Female; Genotype; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Smoking; Stents; Thrombophilia; Ticlopidine; Vasodilation | 2015 |
Low-dose adjunctive cilostazol in patients with complex lesions undergoing percutaneous coronary intervention.
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Safety; Tetrazoles; Ticlopidine; Treatment Outcome | 2016 |
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
Topics: Aged; Aspirin; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Female; Germany; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Registries; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; United States | 2015 |
Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention.
Topics: Aged; Asian People; Aspirin; Blood Platelets; China; Clopidogrel; Coronary Disease; Female; Haplotypes; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Receptors, Cell Surface; Ticlopidine | 2016 |
Genotype Frequencies of CYP2C19, P2Y12 and GPIIIa Polymorphisms in Coronary Heart Disease Patients of Han Ethnicity, and Their Impact on Clopidogrel Responsiveness.
Topics: Aged; Aged, 80 and over; Asian People; China; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Integrin beta3; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Receptors, Purinergic P2Y12; Ticlopidine | 2016 |
Cigarette Smoking Does Not Enhance Clopidogrel Responsiveness After Adjusting VerifyNow P2Y12 Reaction Unit for the Influence of Hemoglobin Level.
Topics: Aged; Biomarkers; Blood Platelets; Clopidogrel; Coronary Disease; Drug-Eluting Stents; Female; Hemoglobins; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Reproducibility of Results; Retrospective Studies; Risk Factors; Smoking; Ticlopidine; Treatment Outcome | 2016 |
Plasma miR-142 accounting for the missing heritability of CYP3A4/5 functionality is associated with pharmacokinetics of clopidogrel.
Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP3A; Female; Humans; Liver; Male; MicroRNAs; Middle Aged; Platelet Aggregation Inhibitors; RNA, Messenger; Ticlopidine | 2016 |
Associations of P2Y12R gene polymorphisms with susceptibility to coronary heart disease and clinical efficacy of antiplatelet treatment with clopidogrel.
Topics: Aged; Blood Platelets; Case-Control Studies; Chromatography, High Pressure Liquid; Clopidogrel; Coronary Disease; Drug Resistance; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Middle Aged; Pharmacogenetics; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Single Nucleotide; Receptors, Purinergic P2Y12; Risk Factors; Ticlopidine; Treatment Outcome | 2016 |
Genomewide Association Study Identifies Novel Genetic Loci That Modify Antiplatelet Effects and Pharmacokinetics of Clopidogrel.
Topics: Aged; ATP Binding Cassette Transporter 1; Biotransformation; China; Clopidogrel; Coronary Disease; Female; Genetic Loci; Genome-Wide Association Study; Humans; Male; Microsomes, Liver; Middle Aged; Models, Biological; Nonlinear Dynamics; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Single Nucleotide; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Site-Specific DNA-Methyltransferase (Adenine-Specific); Ticlopidine; Treatment Outcome | 2017 |
Nonsteroidal anti-inflammatory drugs-induced small bowel enteropathy and obscure gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Capsule Endoscopy; Case-Control Studies; Clopidogrel; Comorbidity; Coronary Disease; Female; Gastrointestinal Hemorrhage; Humans; Intestinal Diseases; Logistic Models; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine | 2018 |
Aspirin desensitization in patients with coronary artery disease: Cost savings.
Topics: Aspirin; Clopidogrel; Coronary Disease; Cost Savings; Desensitization, Immunologic; Drug Hypersensitivity; Drug Substitution; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Salicylates; Ticlopidine | 2017 |
Upper gastrointestinal bleeding in patients with aspirin and clopidogrel co-therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Myocardial Ischemia; Odds Ratio; Platelet Aggregation Inhibitors; Ticlopidine | 2008 |
CHARISMA revisited: is the glass half full or just empty?
Topics: Aspirin; Clopidogrel; Coronary Disease; Disease Progression; Humans; Platelet Aggregation Inhibitors; Primary Prevention; Randomized Controlled Trials as Topic; Registries; Stroke; Ticlopidine | 2008 |
[Resistance to antiplatelet drugs in patients with non ST elevation acute coronary syndrome].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Disease; Drug Resistance; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Severity of Illness Index; Syndrome; Ticlopidine; Treatment Outcome | 2008 |
Safety and efficacy of low-dose clopidogrel in Japanese patients undergoing coronary stenting: preliminary 30-day clinical outcome.
Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Safety; Stents; Ticlopidine; Treatment Outcome | 2008 |
Management and outcome of peptic ulcers or erosions in patients receiving a combination of aspirin plus clopidogrel.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Disease; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Hospitalization; Humans; Male; Peptic Ulcer; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2008 |
Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2008 |
The challenge of monitoring platelet response after clopidogrel.
Topics: Blood Platelets; Clopidogrel; Coronary Disease; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine | 2008 |
[Proton pump inhibition: more than only reflux therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Asthma; Chest Pain; Clopidogrel; Comorbidity; Controlled Clinical Trials as Topic; Coronary Disease; Diagnosis, Differential; Drug Therapy, Combination; Gastroesophageal Reflux; Humans; Omeprazole; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Proton Pump Inhibitors; Rabeprazole; Secondary Prevention; Ticlopidine; Time Factors | 2008 |
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Female; Genotype; Graft Occlusion, Vascular; Homozygote; Humans; Male; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk Factors; Stents; Ticlopidine | 2009 |
Drug-coated coronary stents offer life-saving benefits. A 74-year-old Ohio judge is still presiding in court three years after receiving the implants to reopen a blocked artery.
Topics: Aged; Aspirin; Clopidogrel; Contraindications; Coronary Disease; Drug-Eluting Stents; Humans; Male; Ohio; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Time Factors; Treatment Outcome | 2008 |
The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary
Topics: Aged; China; Clopidogrel; Coronary Disease; Cross-Sectional Studies; Evidence-Based Medicine; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Morbidity; Platelet Aggregation Inhibitors; Prognosis; Risk Assessment; Secondary Prevention; Socioeconomic Factors; Survival Rate; Ticlopidine | 2009 |
Effective platelet inhibition by aspirin and clopidogrel: where are we now?
Topics: Aspirin; Clopidogrel; Coronary Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Ticlopidine; Treatment Failure | 2009 |
Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention.
Topics: Aged; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Disease; Drug Interactions; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Sirolimus; Ticlopidine; Treatment Outcome | 2009 |
Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Chronic Disease; Clopidogrel; Coronary Disease; Disease-Free Survival; Drug Therapy, Combination; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Stents; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2009 |
A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Thrombosis; Ticlopidine; Time Factors | 2009 |
Dual antiplatelet therapy for more than 12 months after percutaneous coronary intervention: insights from the Guthrie PCI Registry.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Drug-Eluting Stents; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2009 |
Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis; Body Mass Index; Clopidogrel; Coronary Disease; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Obesity; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombosis; Ticlopidine | 2009 |
Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network.
Topics: Aged; Algorithms; Cardiovascular Surgical Procedures; Clopidogrel; Cohort Studies; Coronary Disease; Delivery of Health Care, Integrated; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Time Factors; Withholding Treatment | 2009 |
Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population.
Topics: Aged; Algorithms; Cardiovascular Surgical Procedures; Clopidogrel; Cohort Studies; Coronary Disease; Female; Hospitalization; Humans; Male; Managed Care Programs; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Population; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Time Factors; United States; Withholding Treatment | 2009 |
New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.
Topics: Aged; Argentina; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Treatment Outcome | 2009 |
Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Disease; Drug Interactions; Drug Therapy, Combination; Drug-Eluting Stents; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2009 |
Clinical management of clopidogrel inefficiency by point of care platelet function testing and individual adjustment of anti-platelet therapy--initial experiences.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Electric Impedance; Female; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Ticlopidine | 2009 |
Antiplatelet therapy after coronary intervention in Asia and Japan: the Asian perspective of antiplatelet intervention.
Topics: Asia; Cerebral Hemorrhage; Cerebrovascular Disorders; Cilostazol; Clopidogrel; Coronary Disease; Europe; Humans; Liver; North America; Platelet Aggregation Inhibitors; Pyridines; Tetrazoles; Ticlopidine | 2009 |
Individualized antiplatelet therapy: what can a clinical score contribute?
Topics: Adult; Aged; Clopidogrel; Coronary Disease; Coronary Vessels; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Assessment; Safety; Ticlopidine; Young Adult | 2009 |
Impact of P2Y12-ADP receptor polymorphism on the efficacy of clopidogrel dose-adjustment according to platelet reactivity monitoring in coronary artery disease patients.
Topics: Aged; Alleles; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Coronary Artery Disease; Coronary Disease; Female; Genotype; Humans; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Polymorphism, Genetic; Prospective Studies; Receptors, Purinergic P2; Social Adjustment; Ticlopidine | 2010 |
Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation.
Topics: Alleles; Aryl Hydrocarbon Hydroxylases; Blood Platelets; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Female; Genetic Variation; Genotype; Haplotypes; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Stents; Ticlopidine | 2010 |
Stent thrombosis: a poor man's disease?
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Clopidogrel; Cohort Studies; Coronary Disease; Data Interpretation, Statistical; Diabetes Complications; Drug-Eluting Stents; Female; Follow-Up Studies; Housing; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Polytetrafluoroethylene; Residential Facilities; Risk Factors; Smoking; Socioeconomic Factors; Stents; Thrombosis; Ticlopidine; Time Factors | 2009 |
Trial watch. DAPT study.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Multicenter Studies as Topic; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine | 2010 |
Optimal duration of clopidogrel use after implantation of drug-eluting stents--still in doubt.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine | 2010 |
Early and intermediate outcomes of left main coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Vessels; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Survival; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Function, Left | 2010 |
[Balancing act in antithrombotic therapy. Between hemorrhage and embolism].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Phenprocoumon; Proton Pump Inhibitors; Stents; Thromboembolism; Ticlopidine | 2010 |
The case for routine genotyping in dual-antiplatelet therapy.
Topics: Clopidogrel; Coronary Disease; Cytochrome P-450 Enzyme System; Genotype; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2010 |
Late and very late stent thrombosis after polymer-based sirolimus- or paclitaxel-eluting stent implantation in real-world clinical practice.
Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug-Eluting Stents; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Polymers; Sirolimus; Ticlopidine | 2010 |
Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.
Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine | 2010 |
Duration of clopidogrel therapy with drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2010 |
Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Case-Control Studies; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Epinephrine; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Norepinephrine; Platelet Aggregation Inhibitors; Postoperative Care; Statistics, Nonparametric; Stents; Ticlopidine; Treatment Outcome | 2010 |
Duration of clopidogrel therapy with drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2010 |
Duration of clopidogrel therapy with drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Asian People; Aspirin; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Korea; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Ticlopidine | 2010 |
Duration of clopidogrel therapy with drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Asian People; Aspirin; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Life Style; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2010 |
Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy.
Topics: Aged; Alleles; Aryl Hydrocarbon Hydroxylases; Asian People; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Endovascular Procedures; Female; Genotype; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Stents; Ticlopidine | 2011 |
Paraoxonase-1 is a major determinant of clopidogrel efficacy.
Topics: Amino Acid Substitution; Aryldialkylphosphatase; Biotransformation; Clopidogrel; Coronary Disease; Follow-Up Studies; Genotype; Homozygote; Humans; Kinetics; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Stents; Substrate Specificity; Survival Analysis; Ticlopidine; Time Factors | 2011 |
The CHD challenge: comparing four cost-effectiveness models.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Models, Econometric; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Reproducibility of Results; Sensitivity and Specificity; Ticlopidine; United Kingdom | 2011 |
Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Case-Control Studies; Chi-Square Distribution; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Proportional Hazards Models; Proton Pump Inhibitors; Stents; Ticlopidine; Veterans | 2011 |
Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coated Materials, Biocompatible; Coronary Disease; Disease-Free Survival; Endothelial Cells; Female; Humans; Male; Platelet Aggregation Inhibitors; Stem Cells; Stents; Ticlopidine; Vitamin K | 2011 |
Impact of concomitant use of proton-pump inhibitors and thienopyridine derivatives on the antiplatelet effects.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Coronary Disease; Drug Interactions; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Stents; Thienopyridines; Ticlopidine | 2011 |
Significance of cardiocoronary pathology in acute stroke.
Topics: Aspirin; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2011 |
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aryldialkylphosphatase; Aspirin; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Female; Gene Frequency; Genotype; Graft Occlusion, Vascular; Heterozygote; Homozygote; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Stents; Ticlopidine | 2011 |
[Tailored treatment with clopidogrel based on the results of platelet function tests should not be implemented, in the absence of clear indications on the methodology to be used].
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Drug Resistance; Evidence-Based Medicine; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Precision Medicine; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 2011 |
Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy.
Topics: Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Metals; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Sirolimus; Stents; Ticlopidine; Transplantation, Homologous; Treatment Outcome; Tubulin Modulators | 2011 |
Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Chi-Square Distribution; Cilostazol; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Registries; Republic of Korea; Risk Assessment; Risk Factors; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
Predictors of low clopidogrel adherence following percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Female; Humans; Male; Medication Adherence; Middle Aged; New York; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Factors; Surveys and Questionnaires; Texas; Ticlopidine; Treatment Outcome | 2011 |
Relation of body mass index to on-treatment (clopidogrel + aspirin) platelet reactivity.
Topics: Adenosine Diphosphate; Aspirin; Body Mass Index; Cell Adhesion Molecules; Clopidogrel; Coronary Disease; Female; Humans; Logistic Models; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Platelet Aggregation; Platelet Function Tests; Risk Factors; Statistics, Nonparametric; Ticlopidine | 2011 |
[Impact of cytochrome P450 2C19 polymorphisms on outcome of cardiovascular events in clopidogrel-treated Chinese patients after percutaneous coronary intervention].
Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Prognosis; Ticlopidine | 2011 |
Clinical outcomes following coronary stenting in Japanese patients treated with and without proton pump inhibitor.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Asian People; Aspirin; Clopidogrel; Coronary Disease; Female; Follow-Up Studies; Heartburn; Hematemesis; Humans; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Registries; Retrospective Studies; Stents; Stroke; Ticlopidine; Treatment Outcome | 2012 |
No one-size-fits-all: A tailored approach to antithrombotic therapy after stent implantation.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Electrocardiography; Female; Humans; Male; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine | 2012 |
Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease.
Topics: Cardiovascular Diseases; Clopidogrel; Coronary Disease; Drug Interactions; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ticlopidine | 2012 |
Clopidogrel variability: role of plasma protein binding alterations.
Topics: Aged; Aryl Hydrocarbon Hydroxylases; Blood Proteins; Cell Adhesion Molecules; Chromatography, Liquid; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Female; Genotyping Techniques; Humans; Mass Spectrometry; Microfilament Proteins; Middle Aged; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Single Nucleotide; Protein Binding; Statistics as Topic; Ticlopidine | 2013 |
Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Postmenopause; Prospective Studies; Sex Factors; Ticlopidine | 2012 |
[Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori].
Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Clopidogrel; Coronary Disease; Cyclooxygenase 2 Inhibitors; Drug Substitution; Female; Germany; Health Surveys; Helicobacter Infections; Helicobacter pylori; Humans; Internal Medicine; Long-Term Care; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Proton Pump Inhibitors; Surveys and Questionnaires; Ticlopidine | 2012 |
Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Chemoprevention; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medication Adherence; Middle Aged; Secondary Prevention; Ticlopidine | 2013 |
Evidence-based risk stratification to target therapies in acute coronary syndromes.
Topics: Acute Disease; Angina Pectoris; Anticoagulants; Biomarkers; Cardiac Catheterization; Clopidogrel; Coronary Disease; Electrocardiography; Enoxaparin; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Myocardial Infarction; Risk Assessment; Risk Factors; Severity of Illness Index; Ticlopidine; Troponin | 2002 |
CURE works patients with acute coronary syndromes at all risk levels.
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Secondary Prevention; Ticlopidine | 2002 |
A partial CURE for acute coronary syndromes--but how did it happen?
Topics: Angina, Unstable; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2002 |
Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients.
Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Blood Platelets; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Monitoring; Female; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine | 2002 |
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease.
Topics: Blood Platelets; Cell Size; Clopidogrel; Coronary Disease; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2003 |
Clopidogrel-associated angioedema.
Topics: Aged; Angioedema; Clopidogrel; Coronary Disease; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine | 2003 |
Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
Topics: Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Drug Costs; Drug Industry; Fees, Pharmaceutical; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2003 |
Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
Topics: Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk; Ticlopidine | 2003 |
Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
Topics: Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Data Interpretation, Statistical; Drug Costs; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk; Ticlopidine | 2003 |
Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
Topics: Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Drug Costs; Drug Industry; Fees, Pharmaceutical; Health Expenditures; Humans; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Ticlopidine | 2003 |
Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
Topics: Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Humans; Medically Uninsured; Platelet Aggregation Inhibitors; Ticlopidine; United States | 2003 |
Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Antigens, CD; Clopidogrel; Collagen; Coronary Disease; Coronary Thrombosis; Drug Administration Schedule; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Single-Blind Method; Stents; Tetraspanin 24; Ticlopidine | 2003 |
Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
Topics: Adenosine Diphosphate; Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Case-Control Studies; Clopidogrel; Coronary Disease; Female; Humans; Hypertension; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine | 2003 |
A technique for type 4a coronary bifurcation lesions: initial results and 6-month clinical evaluation.
Topics: Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome | 2003 |
Acute coronary syndrome associated with coronary aneurysm: a case report.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiac Catheterization; Clopidogrel; Coronary Aneurysm; Coronary Disease; Diagnosis, Differential; Female; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine | 2003 |
Clopidogrel before urgent coronary artery bypass graft.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Emergency Treatment; Female; Heparin; Humans; Intra-Aortic Balloon Pumping; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Switzerland; Syndrome; Ticlopidine; Treatment Outcome | 2003 |
Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies.
Topics: Acute Disease; Aged; Atorvastatin; Clopidogrel; Comorbidity; Coronary Disease; Drug Interactions; Drug Utilization; Female; Germany; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrroles; Registries; Stroke; Survival Analysis; Syndrome; Ticlopidine; Treatment Outcome | 2003 |
[Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Stroke; Ticlopidine | 2003 |
Clopidogrel in acute coronary syndromes: can the cost effectiveness improve?
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk; Ticlopidine; Treatment Outcome | 2003 |
[Clopidogrel should be added to aspirin for at least 1 year after percutaneous coronary interventions (CREDO) while before them its loading dose can reach 600mg (ISAR-COOL)].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Electrocardiography; Fibrinolytic Agents; Follow-Up Studies; Humans; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine; Time Factors | 2003 |
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Cerebrovascular Disorders; Clopidogrel; Coronary Angiography; Coronary Disease; Equipment Design; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Heart Septal Defects, Atrial; Heart Valve Diseases; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Treatment Outcome; Venous Thrombosis; Warfarin | 2003 |
[Long-term effect of clopidogrel do exist--but hardly worth the costs].
Topics: Clopidogrel; Coronary Disease; Drug Costs; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2003 |
Red vs white thrombi: treating the right clot is crucial.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thrombosis; Ticlopidine | 2003 |
Regression of collateral function after recanalization of chronic total coronary occlusions: a serial assessment by intracoronary pressure and Doppler recordings.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Collateral Circulation; Combined Modality Therapy; Coronary Angiography; Coronary Circulation; Coronary Disease; Female; Follow-Up Studies; Heparin; Humans; Laser-Doppler Flowmetry; Male; Middle Aged; Nitroglycerin; Pressure; Recurrence; Stroke Volume; Ticlopidine; Ultrasonography | 2003 |
Serum sickness-like reaction associated with clopidogrel.
Topics: Acute Disease; Clopidogrel; Coronary Disease; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Serum Sickness; Syndrome; Ticlopidine | 2003 |
Antiplatelet therapy for ischemic heart disease.
Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2004 |
Lack of adverse clopidogrel-atorvastatin clinical interaction.
Topics: Atorvastatin; Clopidogrel; Coronary Disease; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Pyrroles; Research Design; Ticlopidine | 2004 |
When guidelines collide...
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stents; Ticlopidine; Warfarin | 2004 |
Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
Topics: Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine; Warfarin | 2004 |
Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2004 |
Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting.
Topics: Clopidogrel; Coronary Disease; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Stents; Ticlopidine | 2004 |
Different treatments and outcomes of consecutive patients with non-ST-elevation myocardial infarction depending on initial electrocardiographic changes (results of the Acute Coronary Syndromes [ACOS] Registry).
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clopidogrel; Coronary Disease; Coronary Vessels; Drug Utilization; Electrocardiography; Female; Germany; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multivariate Analysis; Myocardial Infarction; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Recurrence; Registries; Stroke Volume; Ticlopidine; Ventricular Dysfunction, Left | 2004 |
807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment.
Topics: Adenosine Diphosphate; Aged; Clopidogrel; Collagen; Coronary Disease; Female; Humans; Integrin alpha2; Male; Middle Aged; Pharmacogenetics; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Stents; Thrombosis; Ticlopidine | 2004 |
Clopidogrel resistance: a new chapter in a fast-moving story.
Topics: Angioplasty; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Eptifibatide; Heparin; Humans; Peptides; Platelet Aggregation Inhibitors; Stents; Thromboxane A2; Ticlopidine; Treatment Outcome | 2004 |
Diminishing returns...and too many choices...the saga of pharmacologic therapy to reduce the complications of percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Disease; Creatine Kinase; Creatine Kinase, MB Form; Humans; Isoenzymes; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Troponin I | 2004 |
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; C-Reactive Protein; Case-Control Studies; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Reference Values; Risk Assessment; Severity of Illness Index; Ticlopidine; Treatment Outcome | 2004 |
Long-term clopidogrel therapy in the drug-eluting stent era: beyond CREDO and PCI-CURE.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2004 |
[Do low risk patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel need abciximab infusion? Results of ISAR-REACT study].
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Infusions, Parenteral; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine; Time Factors | 2004 |
Clopidogrel and postoperative bleeding.
Topics: Aprotinin; Aspirin; Blood Transfusion; Cardiopulmonary Bypass; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Extracorporeal Circulation; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prospective Studies; Stents; Ticlopidine; Time Factors | 2004 |
Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Eptifibatide; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stents; Ticlopidine | 2005 |
Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
Topics: Aged; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Female; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Premedication; Prospective Studies; Reoperation; Risk Factors; Thrombosis; Ticlopidine | 2005 |
The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Computer Simulation; Coronary Disease; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Markov Chains; Middle Aged; Models, Economic; Monte Carlo Method; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors | 2005 |
Anaesthetic considerations in a parturient with critical coronary artery disease and a drug-eluting stent presenting for caesarean section.
Topics: Adult; Anesthesia, Obstetrical; Cesarean Section; Clopidogrel; Coronary Disease; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Stents; Ticlopidine | 2005 |
P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose.
Topics: Adenosine Diphosphate; Aged; Aspirin; Clopidogrel; Coronary Disease; Female; Genotype; Haplotypes; Humans; Male; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Receptors, Cell Surface; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine | 2005 |
Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angina, Unstable; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Drug Resistance; Female; Humans; Male; Middle Aged; Myocardial Infarction; Norway; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Stroke; Ticlopidine | 2004 |
Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes.
Topics: Adenosine Monophosphate; Calcium Signaling; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Receptors, Thrombin; Ticlopidine | 2005 |
[Exercise-induced left arm pain and thrombocytosis].
Topics: Angioplasty, Balloon, Coronary; Bone Marrow Examination; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Stenosis; Coronary Thrombosis; Diagnosis, Differential; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Risk Factors; Smoking; Stents; Thrombocythemia, Essential; Ticlopidine | 2005 |
Stent thrombosis is associated with an impaired response to antiplatelet therapy.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Thrombosis; Ticlopidine | 2005 |
Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Case-Control Studies; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Thrombosis; Ticlopidine | 2005 |
The value of clopidogrel administered postoperatively following a non-ST-segment elevation acute coronary syndrome.
Topics: Clopidogrel; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Humans; Male; Myocardial Infarction; Postoperative Complications; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Ticlopidine; Treatment Outcome | 2005 |
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Blood Platelets; CD40 Ligand; Cholesterol; Cholesterol, LDL; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Interactions; Female; Flow Cytometry; Heptanoic Acids; Humans; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine; Triglycerides | 2005 |
A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK.
Topics: Acute Disease; Aged; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Drug Costs; Electrocardiography; Humans; Markov Chains; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
Combined pharmacologic treatment with clopidogrel and statin for patients with acute coronary syndrome: is there a survival advantage?
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Combinations; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Survival Analysis; Ticlopidine | 2005 |
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2005 |
Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine | 2005 |
[Prophylaxis of stroke].
Topics: Age Factors; Aged; Angioplasty, Balloon; Anticoagulants; Antihypertensive Agents; Aspirin; Atrial Fibrillation; Brain Ischemia; Carotid Stenosis; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diet; Drug Therapy, Combination; Endarterectomy, Carotid; Exercise; Female; Humans; Hypertension; Hypolipidemic Agents; Life Style; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Sex Factors; Smoking Cessation; Stents; Stroke; Ticlopidine; Time Factors | 2005 |
PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.
Topics: Alleles; Blood Coagulation Factors; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genetic Variation; Genotype; Homozygote; Humans; Male; Membrane Proteins; Middle Aged; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptor, PAR-1; Receptors, Purinergic P2Y12; Receptors, Thrombin; Ticlopidine | 2005 |
Clopidogrel hypersensitivity syndrome with rash, fever, and neutropenia.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Drug Hypersensitivity; Female; Fever; Humans; Nausea; Neutropenia; Platelet Aggregation Inhibitors; Stents; Syndrome; Tachycardia; Ticlopidine; Vomiting | 2005 |
Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting.
Topics: Aged; Chemical and Drug Induced Liver Injury; Clopidogrel; Combined Modality Therapy; Coronary Disease; Humans; Male; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2005 |
Use of evidence-based management for acute coronary syndrome.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Cardiology; Clopidogrel; Coronary Angiography; Coronary Disease; Evidence-Based Medicine; Female; Guideline Adherence; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Revascularization; New Zealand; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Retrospective Studies; Thrombolytic Therapy; Ticlopidine | 2005 |
Acute polyarthritis associated with clopidogrel treatment.
Topics: Acute Disease; Arthritis; Clopidogrel; Coronary Disease; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine | 2005 |
Prior clopidogrel use and outcome of acute coronary syndrome.
Topics: Aspirin; Clopidogrel; Coronary Disease; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2006 |
Letter regarding article by Valgimigli et al, "Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease".
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Implants; Humans; Platelet Aggregation Inhibitors; Radiography; Stents; Ticlopidine | 2005 |
Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.
Topics: Aspirin; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Tetrazoles; Thrombosis; Ticlopidine | 2005 |
Evolving role of clopidogrel in acute coronary syndromes.
Topics: Acute Disease; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine | 2005 |
Case 6-2005 thoracotomy after myocardial infarction and intracoronary stenting: a balance between myocardial recovery and procedural risk.
Topics: Clopidogrel; Coronary Disease; Exercise Test; Female; Humans; Lung; Lung Neoplasms; Middle Aged; Myocardial Infarction; Oxygen Consumption; Platelet Aggregation Inhibitors; Risk; Stents; Thoracotomy; Ticlopidine | 2005 |
Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Recurrence; Survival Analysis; Ticlopidine | 2006 |
Clinical, biochemical and genetical resistance to clopidogrel in a patient with the recurrent coronary stent thrombosis--a case report and review of the literature.
Topics: Aged; Clopidogrel; Coronary Angiography; Coronary Disease; Drug Resistance; Female; Humans; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine | 2006 |
Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Artery Bypass, Off-Pump; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Period; Prospective Studies; Recurrence; Regression Analysis; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome | 2006 |
Variable therapeutic effectiveness of clopidogrel in acute coronary syndromes.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Premedication; Secondary Prevention; Stents; Syndrome; Ticlopidine | 2006 |
Impact of adenosine diphosphate and calcium chelation on platelet aggregation testing in patients receiving clopidogrel therapy.
Topics: Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Chelating Agents; Citrates; Clopidogrel; Coronary Disease; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Sodium Citrate; Ticlopidine | 2006 |
Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor.
Topics: Adolescent; Adult; Blood Platelets; Clopidogrel; Coronary Disease; Drug Resistance; Electric Impedance; Female; Humans; Male; Membrane Proteins; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine | 2006 |
[Inhibition of platelet aggregation for the secondary prevention after ACS: when clopidogrel instead of ASA, when clopidogrel and ASA?].
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine | 2006 |
High postclopidogrel platelet reactivity in non-ST-elevation acute coronary syndrome treated with stenting: a clue for adverse prognosis?
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Premedication; Secondary Prevention; Stents; Syndrome; Ticlopidine | 2006 |
Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study.
Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Restenosis; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome | 2006 |
[The effect of paclitaxel-eluting stents on restenosis].
Topics: Animals; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Random Allocation; Secondary Prevention; Stents; Swine; Ticlopidine; Tunica Intima; Ultrasonography, Interventional | 2006 |
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Disease; Coronary Restenosis; Coronary Stenosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Implants; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Internet; Male; Middle Aged; Myocardial Infarction; Product Surveillance, Postmarketing; Registries; Risk Factors; Sirolimus; Stents; Thrombosis; Ticlopidine; United States | 2006 |
Concurrent use of clopidogrel (Plavix) and atorvasatin (Lipitor) is contraindicated.
Topics: Atorvastatin; Clopidogrel; Contraindications; Coronary Disease; Drug Incompatibility; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine | 2006 |
[Recurrent hemoptysis following thienopyridines and amiodarone administration. therapeutic dilemma].
Topics: Aged; Amiodarone; Cardiovascular Agents; Clopidogrel; Coronary Disease; Drug Interactions; Drug Therapy, Combination; Hemoptysis; Humans; Male; Platelet Aggregation Inhibitors; Pyridines; Recurrence; Ticlopidine | 2005 |
Use of ticlopidine and cilostazol after intracoronary drug-eluting stent placement in a patient with previous clopidogrel-induced thrombotic thrombocytopenic purpura: a case report.
Topics: ADAM Proteins; ADAMTS1 Protein; Aged; Apoptosis; Aspirin; Autoantibodies; Cilostazol; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Plasmapheresis; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Stents; Tetrazoles; Ticlopidine | 2006 |
Unveiling the inflammatory face of antiplatelet drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Humans; Inflammation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Up-Regulation | 2006 |
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.
Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine | 2006 |
A study comparing the incidence and predictors of creatine kinase MB and troponin T release after coronary angioplasty. Does Clopidogrel preloading reduce myocardial necrosis following elective percutaneous coronary intervention?
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Clopidogrel; Cohort Studies; Coronary Disease; Creatine Kinase, MB Form; Elective Surgical Procedures; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardium; Necrosis; Platelet Aggregation Inhibitors; Preoperative Care; Sensitivity and Specificity; Ticlopidine; Troponin T; United Kingdom | 2007 |
Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin.
Topics: Aged; Angioplasty; Aryl Hydrocarbon Hydroxylases; Aspirin; Cell Adhesion Molecules; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Drug Antagonism; Enzyme Inhibitors; Female; Humans; Male; Microfilament Proteins; Mixed Function Oxygenases; Omeprazole; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Single Nucleotide; Protein Processing, Post-Translational; Thrombosis; Ticlopidine | 2006 |
Tackling the diabetic platelet: is high clopidogrel dosing the answer?
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thrombosis; Ticlopidine | 2006 |
[Cost-effectiveness of clopidogrel vs. aspirin treatment in high-risk acute coronary syndrome patients in Denmark].
Topics: Acute Disease; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Cost-Benefit Analysis; Humans; Ischemia; Leg; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Syndrome; Ticlopidine | 2006 |
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aspirin; Clopidogrel; Coronary Disease; Diabetes Complications; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Research Design; Risk Assessment; Stress, Mechanical; Syndrome; Ticlopidine; Time Factors; von Willebrand Factor | 2006 |
[Bleeding complications after treatment with antithrombotic agents after acute coronary syndrome].
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Ticlopidine | 2006 |
Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
Topics: Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Cross-Sectional Studies; Drug Therapy, Combination; Endpoint Determination; Female; Heart Conduction System; Hemorrhage; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Registries; Ticlopidine; Treatment Outcome; United States | 2006 |
A cost analysis in patients with acute coronary syndrome using clopidogrel in addition to aspirin in a Hong Kong public hospital.
Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Costs and Cost Analysis; Female; Hong Kong; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Syndrome; Ticlopidine | 2006 |
Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach").
Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Aspirin; Clopidogrel; Coronary Disease; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Prospective Studies; Stents; Ticlopidine | 2006 |
Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation Inhibitors; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Stroke Volume; Survival Analysis; Ticlopidine | 2007 |
Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Female; Flow Cytometry; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2007 |
A new caution for patients with drug-coated stents.
Topics: Clopidogrel; Coronary Disease; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Refusal | 2006 |
Platelet non-responsiveness to dual antiplatelet therapy and relation to coronary disease among diabetes patients.
Topics: Adult; Aspirin; Blood Platelets; Case-Control Studies; Clopidogrel; Coronary Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Reference Values; Risk Assessment; Ticlopidine; Treatment Failure | 2007 |
Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.
Topics: Adenosine Diphosphate; Blood Platelets; Clopidogrel; Coronary Disease; Diabetic Angiopathies; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2007 |
Variability in response to clopidogrel: where is the threshold for 'low response'?
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Stroke; Ticlopidine; Treatment Failure | 2007 |
Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Recurrence; Risk Assessment; Syndrome; Ticlopidine | 2007 |
Acute coronary syndrome in an adult with anomalous origin of the left anterior descending coronary artery from the pulmonary trunk.
Topics: Adrenergic beta-Antagonists; Cardiac Catheterization; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Vessel Anomalies; Echocardiography; Electrocardiography; Female; Humans; Middle Aged; Ticlopidine | 2007 |
Endpoints in studies on myocardial infarction.
Topics: Clopidogrel; Coronary Disease; Endpoint Determination; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine | 2007 |
Managing acute coronary syndrome: evidence-based approaches.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Clinical Protocols; Clopidogrel; Coronary Disease; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Recombinant Proteins; Ticlopidine | 2007 |
Timing of thrombotic events in patients receiving 2 weeks of clopidogrel therapy post bare metal coronary artery stenting: a New Zealand retrospective study.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine; Withholding Treatment | 2007 |
Clopidogrel and stent thrombosis after percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2007 |
Surgery or percutaneous coronary intervention for three-vessel and left main coronary artery disease: a critical appraisal of the literature.
Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2007 |
Clopidogrel: the good, the bad, and the ugly.
Topics: Acute Disease; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine | 2007 |
PCI for stable coronary disease.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2007 |
[After coronary intervention. Which platelet inhibitor for whom?].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coated Materials, Biocompatible; Coronary Disease; Cost Control; Drug Costs; Drug Therapy, Combination; Germany; Humans; Myocardial Infarction; National Health Programs; Platelet Aggregation Inhibitors; Secondary Prevention; Stents; Ticlopidine | 2007 |
[Coronary heart disease patient does not tolerate acetylsalicylic acid. Can clopidogrel be prescribed?].
Topics: Aspirin; Clopidogrel; Contraindications; Coronary Disease; Drug Therapy, Combination; Humans; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2007 |
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Topics: Acute Coronary Syndrome; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Chronic Disease; Clopidogrel; Contraindications; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Coronary Stenosis; Drug-Eluting Stents; Electrocardiography; Evidence-Based Medicine; Exercise Test; Humans; Kidney Diseases; Myocardial Infarction; Nomograms; Patient Selection; Platelet Aggregation Inhibitors; Prognosis; Radionuclide Ventriculography; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Stents; Stroke Volume; Thrombolytic Therapy; Ticlopidine | 2008 |
Management of upper gastrointestinal haemorrhage complicating dual anti-platelet therapy.
Topics: Aged; Aspirin; Blood Transfusion; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Platelet Count; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 2008 |
A retrospective study of the management of retro-peritoneal bleeding after percutaneous coronary intervention in the era of combination anti-platelet therapy.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Female; Femoral Artery; Follow-Up Studies; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Length of Stay; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retroperitoneal Space; Retrospective Studies; Ticlopidine; Treatment Outcome | 2008 |
[Influence of statins on the antiplatelet effect of clopidogrel and on cardiovascular outcome in patients after coronary intervention].
Topics: Atorvastatin; Clopidogrel; Coronary Disease; Coronary Stenosis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Stents; Ticlopidine | 2008 |
For better or for worse: the future of antiplatelet therapy.
Topics: Acute Coronary Syndrome; Clopidogrel; Coronary Disease; Forecasting; Hemorrhage; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Stroke; Thiophenes; Thrombolytic Therapy; Thrombosis; Ticlopidine | 2008 |
Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology.
Topics: Abciximab; Alanine; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Benzamidines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Disease; Dalteparin; Defibrillators, Implantable; Double-Blind Method; Enalapril; Endothelial Growth Factors; Fatty Acids, Omega-3; Guanidines; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Laser Therapy; Lymphokines; Metoprolol; Multicenter Studies as Topic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pyrrolidines; Randomized Controlled Trials as Topic; Simvastatin; Sodium-Hydrogen Exchangers; Stents; Sulfones; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E | 1999 |
Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine; Treatment Outcome | 1999 |
Taming platelets in coronary stenting: ticlopidine out, clopidogrel in?
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Disease; Humans; Stents; Ticlopidine | 1999 |
[Clopidogrel--an expensive thrombocyte inhibitor with a small marginal benefit].
Topics: Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine | 2000 |
Combination therapy with clopidogrel and aspirin after coronary stenting.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine; Treatment Outcome | 2000 |
Consider this: It's too little!
Topics: Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2000 |
Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine.
Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Blood Vessel Prosthesis Implantation; Cardiac Catheterization; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Incidence; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stents; Thrombocytopenia; Thrombolytic Therapy; Ticlopidine | 2000 |
Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient.
Topics: Adult; Clopidogrel; Coronary Disease; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Plasmapheresis; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Ticlopidine | 2000 |
Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Disease; Cost-Benefit Analysis; Drug Costs; Equipment Design; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Registries; Stents; Ticlopidine | 2000 |
Risk of neutropenia with clopidogrel.
Topics: Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Disease; Graft Occlusion, Vascular; Humans; Neutropenia; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2000 |
Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Thrombosis; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional | 2001 |
[Pharmacy clinics. Medication of the month. Clopidogrel (Plavix)].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Myocardial Ischemia; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine | 2001 |
[Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery].
Topics: Aspirin; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2001 |
Diffuse alveolar hemorrhage after clopidogrel use.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Hemorrhage; Humans; Lung Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Radiography; Ticlopidine | 2001 |
Current perspectives on British use of adjunctive therapies during coronary interventions.
Topics: Abciximab; Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Combined Modality Therapy; Coronary Disease; Heparin; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Patterns, Physicians'; Ticlopidine; United Kingdom | 2001 |
Clopidogrel in invasive management of non-ST-elevation ACS.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Humans; Myocardial Ischemia; Myocardial Revascularization; Platelet Aggregation Inhibitors; Preoperative Care; Ticlopidine; Treatment Outcome | 2001 |
Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban).
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine | 2001 |
Statins do not affect platelet inhibition with clopidogrel during coronary stenting.
Topics: Aged; Clopidogrel; Coronary Disease; Coronary Vessels; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2001 |
Evaluating the risks of therapies for acute coronary syndromes.
Topics: Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine | 2001 |
Clopidogrel and percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Disease; Double-Blind Method; Humans; Platelet Aggregation Inhibitors; Premedication; Pyridines; Research Design; Stents; Survival Analysis; Ticlopidine; Treatment Outcome | 2002 |
Guidelines for acute coronary syndrome without ST elevation.
Topics: Clopidogrel; Coronary Disease; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Ticlopidine | 2002 |
[Clopidrogel in Acute Coronary Syndromes with Non-ST Elevation].
Topics: Acute Disease; Clopidogrel; Coronary Disease; Electrocardiography; Humans; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine | 2002 |
Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Computer Simulation; Coronary Disease; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Humans; Middle Aged; Models, Econometric; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Ticlopidine | 2002 |
When increased therapeutic benefit comes at increased cost.
Topics: Aspirin; Clopidogrel; Coronary Disease; Cost-Benefit Analysis; Drug Costs; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Ticlopidine | 2002 |
ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Topics: Adenosine Diphosphate; Animals; Apyrase; Bridged Bicyclo Compounds, Heterocyclic; Clopidogrel; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hydrazines; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin; Thromboxane A2; Ticlopidine | 1992 |